Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells

Abstract

Epithelial and mucosal barriers are critical interfaces physically separating the body from the outside environment and are the tissues most exposed to microorganisms and potential inflammatory agents. The integrity of these tissues requires fine tuning of the local immune system to enable the efficient elimination of invasive pathogens while simultaneously preserving a beneficial relationship with commensal organisms and preventing autoimmunity. Although they only represent a small fraction of circulating and lymphoid T cells, γδ T cells form a substantial population at barrier sites and even outnumber conventional αβ T cells in some tissues. After their egress from the thymus, several γδ T cell subsets naturally establish residency in predetermined mucosal and epithelial locations, as exemplified by the restricted location of murine Vγ5⁺ and Vγ3Vδ1⁺ T cell subsets to the intestinal epithelium and epidermis, respectively. Because of their preferential location in barrier sites, γδ T cells are often directly or indirectly influenced by the microbiota or the pathogens that invade these sites. More recently, a growing body of studies have shown that γδ T cells form long-lived memory populations upon local inflammation or bacterial infection, some of which permanently populate the affected tissues after pathogen clearance or resolution of inflammation. Natural and induced resident γδ T cells have been implicated in many beneficial processes such as tissue homeostasis and pathogen control, but their presence may also exacerbate local inflammation under certain circumstances. Further understanding of the biology and role of these unconventional resident T cells in homeostasis and disease may shed light on potentially novel vaccines and therapies.

Introduction

Epithelial and mucosal tissues form physical barriers separating the body from the outside world. They are constantly exposed to a wide range of stressors such as infectious agents and their toxins capable of damaging barrier tissues. Barrier surface interactions with microorganisms extend far beyond encounters with pathogenic microbes; indeed, these tissues are typically mutualistic ecosystems that maintain beneficial relationships for resident commensal organisms while providing support to the tissue (1). Because of the complexity of these interfaces, the immune system is tightly regulated in order to eliminate invading pathogens while maintaining a robust commensal environment. It is now well established that the microbiota plays a significant role in educating immune cells and promoting protective anti-infectious responses (2–4). However, the microbiota may also play an important role in aberrant inflammation (5, 6). In addition, pathogenic agents also leave their imprint on the immune system and generate long-lasting memory responses. Protective immunity has mainly been the purview of conventional effector memory (T_EM) or central memory (T_CM) T cells and B cells. More recently, the discovery of conventional resident memory T cells (T_RM) (7, 8), innate immune memory also known as trained immunity (9, 10), and other unconventional memory responses (11, 12) has focused attention on tissue-specific immunity at barrier locations.

γδ T cells are an unconventional T cell population that display immunologic features common to both the innate and adaptive immune systems (13). This dual nature of γδ T cell biology is typified by their non-MHC-restricted antigenic specificity while mounting rapid immune responses to a wide range of tissue stressors (14), generally referred to as “lymphoid-stress surveillance” (15). γδ T cells are the first T cells generated during embryonic development and quickly seed peripheral tissues where specialized subsets are maintained for life in residence. These unconventional T cells are only found at low frequencies in lymphoid tissues and the blood in adult humans and rodents; however, they are enriched in epithelial and mucosal tissues (16–19). Generally, distinct barrier tissues harbor mostly non-overlapping γδ T cell subsets with non-redundant functions (17). Some tissues contain unique and highly specialized γδ T cell subsets that are not found elsewhere in the body. For example, Vγ3Vδ1⁺ skin dendritic epidermal T cells (DETC) reside exclusively in the skin epidermis while Vγ5⁺ T cells reside exclusively in the intestinal epithelium [the Garman nomenclature (20) is used throughout this review for murine γδ T cells] (21). The development and selection processes that regulate the differentiation of these cells are unique and result in the generation of highly adapted cells that actively survey neighboring cells, sense and respond to stresses of various nature and participate in many tissue processes. Thus, these natural tissue-resident γδ T cells are programmed sentinels that are also shaped by and highly adapted to their tissue environment.

Because of their preferential location in barrier sites, γδ T cells are often directly or indirectly influenced by the microbiota or the pathogens that invade these sites. The steady-state microbiota may influence the generation, effector functions, or maintenance of γδ T cells (22–24). These commensal-induced γδ T cells adapt to their tissue of residence where they add another level of immune surveillance and may be mobilized in many pathological contexts including inflammation (25–27) and cancer (28, 29). These tissue-resident γδ T cells are also mobilized during infection to promote anti-pathogen immunity (30) and represent innate first responders during infection. Alternatively, pathogen-induced adaptive γδ T cells appear to follow a more conventional T cell maturation pathway, resulting in delayed activation and expansion while favoring the establishment of long-lasting memory and heightened protective potential upon pathogen re-exposure. Throughout this review, the term “adaptive” will be utilized to describe γδ T cells having features consistent with conventional αβ T cells. This review will focus on the tissue adaptation of tissue-resident natural γδ T cells and adaptive γδ T_RM cells in barrier tissues while highlighting their development, maintenance and role in health and disease.

γδ T cells of humans and mice

Murine γδ T cells are often segregated into different subsets based on their Vγ T cell receptor (TCR) chain, as it is generally associated with tissue tropism and a bias in effector function (31, 32) (Table 1). It is well established that γδ T cell ontogeny is temporally controlled and manifested by “waves” of development (76). The factors regulating γδ T cell development have been recently reviewed (77, 78). Most barrier tissue γδ T cells develop early during fetal development in the fetal/neonatal thymus with the first thymic wave of γδ T cells starting at embryonic day 13 and giving rise to DETC characterized by surface expression of an invariant Vγ3Vδ1 TCR (16). Vγ3Vδ1⁺ DETC migrate to the skin epidermis (18, 76, 79) and produce IFNγ (80) and other cytokines (81, 82), and growth factors (83, 84). From embryonic day 14 to the perinatal period, the fetal/neonatal thymus generates other innate-like [also called “natural” (85)] γδ T cells, including the IL-17A biased quasi-invariant Vγ4Vδ1⁺ T cells which preferentially migrate to the genital tract, the tongue and the lungs (16, 76, 86). Fetal-derived γδ T cells are typically considered innate-like due to their reduced TCR sensitivity (87) and rapid functional response to innate stimuli like cytokines and pathogen- or danger-associated molecular patterns (72, 88, 89). IL-17A-producing γδ T cells (referred to as γδ17 T cells in this review) are characterized by the expression of the transcription factor RORγt (90), chemokine receptor CCR6 (86, 90, 91), scavenger receptor SCART2 (92), CD25 (93), but lack CD27 (86, 90, 94). In contrast, IFNγ-producing γδ T cells express the transcription factor T-bet and surface receptors NK1.1 and CD27. Consistent with other IFNγ producing lymphocytes, they also express high levels of the IL-2/IL-15 receptor β chain CD122 (93, 95). It was initially thought that γδ17 T cells acquired their peripheral effector fate due to a lack of antigenic selection in the thymus; antigen-experienced cells were programmed to make IFNγ in the periphery while antigen-inexperienced cells were programmed to make IL-17A (80, 87, 95, 96). However, recent evidence suggests that signaling through the TCR is required for γδ17 T cells development and that the strength of the signal is the critical factor determining their functional lineage. A strong TCR signal promotes an IFNγ-dominant lineage whereas a weak TCR signal promotes an IL-17A-dominant lineage (97–99). An additional level of regulation comes from the thymic cytokine milieu: while signaling through IL-15Rα restrains γδ17 T cell development in cis (100), IL-7 promotes their expansion (101). An interesting feature of γδ17 T cells is their functional plasticity, which allows them to co-produce IL-17A and IFNγ under certain circumstances (61, 102). Although CD27⁻ γδ T cells have a permissive chromatin state at the Il17a and Ifng loci, only a handful of situations have been associated with IL-17A and IFNγ co-production in vivo, including oral Listeria monocytogenes (L. monocytogenes) infection (61, 62) and peritoneal tumor (102). Post-transcriptional repression of IFNγ production has recently been reported in γδ17 T cells (61); however, whether co-production of IL-17A and IFNγ is regulated by derepression has not been evaluated.

Although most γδ17 T cells fall into the innate-like category, adaptive-like differentiation of naïve γδ T cell precursors into mature γδ17 T cells in peripheral lymphoid organs has also recently been reported in multiple models. After the identification of phycoerythrin (PE) as a γδTCR antigen, PE-specific γδ T cells were shown to transition from a naïve CD44^lo CD62L^hi to an activated CD44^hi CD62L^lo phenotype after immunization with PE (103). These γδ T cells expressed RORγt and inflammatory cytokine receptors IL-1R1 and IL-23R which drove production of IL-17A without extensive proliferation (103). Similarly, imiquimod (IMQ)-induced skin inflammation and MOG-induced experimental autoimmune encephalomyelitis (EAE) induced the de novo generation of γδ17 T cells in draining lymph nodes (104, 105). These unrelated models demonstrate that the differentiation of some γδ17 T cell subsets is optimal with a TCR signal and in the presence of IL-23, reminiscent of the multistep development of naïve CD4⁺ T cells. In contrast to natural γδ17 T cells, these de novo generated cells are often referred to as inducible γδ17 T cells (14).

γδ T cell subsets in human and non-human primates are generally divided into two major populations based on the Vδ TCR chain: Vδ2⁺ and Vδ2⁻ γδ T cells. Vδ2⁺ T cells appear to develop almost exclusively in the fetal liver and fetal thymus (106, 107) and form the predominant γδ T cell population in the peripheral blood of adult humans (108, 109). Most fetal, cord blood and adult Vδ2⁺ T cells express the semi-invariant Vγ9Vδ2 TCR with a public germline encoded CDR3γ sequence and a more diverse CDR3δ sequence (110). Despite their preferential localization in the blood, Vγ9Vδ2⁺ T cells can also be recruited to inflamed tissues where they can participate in pathogen clearance or promote inflammation (39, 45, 47) (Table 1). The TCR combination allows the majority of Vγ9Vδ2⁺ T cells to recognize prenyl pyrophosphate metabolites (111), broadly referred to as phosphoantigens (PAgs), presented in the context of butyrophilin (BTN)3A1 and BTN3A2 (112–115). PAgs are metabolic intermediates produced by the eukaryotic mevalonate pathway and the microbial 2-C-methyl-D-erythriol 4-phosphate (MEP) pathway, which generates one of the most potent Vγ9Vδ2⁺ T cell activator (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) (111). Fetal Vγ9Vδ2⁺ T cells express genes found in adult cells and can expand and produce IFNγ in response to HMBPP stimulation (110). By 1 year of age, almost all Vγ9Vδ2⁺ T cells have acquired a memory phenotype and can rapidly produce IFNγ and cytotoxic molecules (108, 116), similar to circulating adult cells (108, 116, 117). These data suggest that human Vγ9Vδ2⁺ T cells are preprogrammed fetal-derived effectors with a restricted TCR specificity. Thus, Vγ9Vδ2⁺ T cells seem to belong to the natural, innate-like population of lymphocytes.

In contrast to Vγ9Vδ2⁺ T cells, the Vδ2⁻ γδ T cell subset is heterogenous (106) and preferentially resides in epithelial tissues such as the skin (118) and intestines (119) and appears to form resident populations in the liver (120) (Table 1). Vδ2⁻ γδ T cells mainly consist of Vδ1⁺ T cells, with fewer Vδ3⁺ and Vδ5⁺ T cells. While most antigens recognized by Vδ2⁻ γδ T cells remain unknown, the antigens identified to date suggest a broad reactivity to MHC-like molecules like endothelial protein C receptor (EPCR) (33) and CD1 molecules (33, 121, 122), stress-induced ligands (123) and algal phycoerythrin (103). Vδ2⁻ γδ T cell TCR are highly diverse in cord blood but their TCR repertoire becomes more restricted into adulthood (124). Furthermore, they clonally expand in response to cytomegalovirus (CMV) infection and differentiate into CD45RA⁺ effector memory T (T_EMRA) cells (34, 35, 125–127). Thus, the Vδ2⁻ γδ T cell repertoire appears to be shaped by TCR-dependent selection events mediated by microbial encounters throughout life. As Vδ2⁻ γδ T cells can recognize stress antigens, non-infectious events that trigger a response, such as cancer development, may also shape their repertoire (36, 128).

γδ T cells can provide different physiologic roles depending on the nature and context of the insult, the tissue involved and the γδ T cell populations mobilized. At steady state, γδ T cells are involved in many biological processes aiming at maintaining barrier integrity (e.g., by promoting epithelial cell survival and homeostasis) (82–84, 129) and regulating thermogenesis (130). Because of their rapid sensing of stress and recruitment to inflamed sites, γδ T cells are often involved in shaping early immunologic events. They can promote the activation, maturation, and recruitment of dendritic cells (DC), neutrophils, B cells, and conventional T cells [for a detailed review see (131)]. γδ T cells are also a direct and potent source of critical inflammatory cytokines like IFNγ, TNFα and IL-17A in many pathological contexts, including infection (59, 111, 132–134), autoimmune disease (25, 26, 72, 135) and cancer (29, 136–138). As such, they are also an integral part of the effector response. At later phases, γδ T cells can promote the resolution of the inflammation through the production of anti-inflammatory molecules like TGFβ (139, 140). Finally, they sustain tissue repair and remodeling after infection or injury (54, 83, 132, 141). Thus, γδ T cells are critically involved in regulating health during homeostasis and disease.

The first tissue-resident T cells: intestinal and epidermal γδ T cells

Many γδ T cell subsets are constrained to specific tissue locations. DETC and intestinal intraepithelial lymphocytes (IEL) with a γδTCR (γδ IEL) populate the two largest interfaces of the body, the skin and the intestines, respectively. DETC and γδ IEL are shaped within their respective tissues where they provide adapted support to maintain tissue homeostasis and respond to stresses or invading pathogens. These populations have recently been the focus of an in-depth review (21). Thus, only features relevant to this review will be discussed here.

Dendritic epidermal T cells– DETC

DETC are the first T cells to develop during embryogenesis and by far the most abundant T cell subset present in the mouse skin epidermis (142). Their name stems from the unique DC-like morphology observed during homeostasis. DETC form a highly uniform population characterized by the expression of a canonical Vγ3Vδ1 TCR with no junctional diversity. The mouse fetal thymus supports the generation of the entire DETC precursor pool between embryonic day 13 and 18, after which mature DETC are maintained life-long in the skin epidermis by self-renewal (18, 76, 79, 143). The narrow developmental window of DETC progenitors may result from the temporally restricted expression of a Btn-like protein, Skint-1, by embryonic medullary thymic epithelial cells (144–146). Expression of Skint-1 is required at various stages of DETC thymic development to regulate their biology. First, Skint-1 promotes the thymic maturation of Vγ3Vδ1⁺ T cell progenitors, without which the skin epidermis would be devoid of mature DETC (144–146). Second, Skint-1 educates DETC precursors by promoting IFNγ production over IL-17A (80), instructing skin-homing (147), and attenuating TCR responsiveness by increasing its activation threshold (87). Similarly, TCR signaling seems required for the maturation of DETC precursors (148–150) and the establishment of a mature population with innate-like properties in the skin epidermis (87, 148–151). It is also indirectly involved in the thymic egress and subsequent migration to the skin of positively selected progenitor cells. Indeed, TCR signaling induced the expression of sphingosine-1-phosphate receptor 1 (S1P1) and the skin-homing chemokine receptor CCR10, which mediates T cell exit from the thymus and migration toward keratinocyte-derived CCL27, respectively (152, 153). Additional molecules like E- and P-selectin ligands and CCR4 may also play a role in the establishment or maintenance of the DETC population in the skin (154).

During homeostasis, mature DETC are maintained in a semi-activated state and constantly survey the epidermis through the extension of motile basal dendrites and by projecting dendrites toward the apical epidermis. These dendrites establish stable synapses at the squamous keratinocyte junctions that allows DETC to survey several surrounding cells simultaneously (155). Each apical dendrite ends with phosphorylated tyrosine–rich aggregates in synapse-like structures enriched with TCR and phosphorylated TCR signaling intermediates. Therefore, mature DETC might receive continuous TCR-mediated signals from neighboring cells residing in the epidermis, which are necessary for their long-term maintenance in the tissue (156). Although healthy skin does not appear to express DETC TCR ligand detectable by soluble Vγ3Vδ1 TCR tetramers (157), exposure of the skin to low grade stresses might sustain basal expression of ligands sufficient for their survival but below the sensitivity of this detection method. Indeed, DETC express basal levels of the type-2 cytokine IL-13 in resting skin, consistent with some level of activation at steady state (82). Absence of DETC-derived IL-13 induces an epithelial cell stress response that disrupts barrier integrity. As such, DETC play a key role in preserving skin homeostasis at steady state.

The skin is constantly exposed to a variety of pathological conditions and stresses. Superficial damage to the epithelium induces a stress response associated with upregulation of the NKG2D ligand Rae-1 and leads to the further activation of DETC (82, 158). Enhanced production of DETC-derived IL-13 induces keratinocyte maturation, which promotes efficient epithelial cell renewal, restoring tissue integrity (82). Shortly after deep wounding, damaged keratinocytes in close proximity to the lesion quickly and transiently upregulate a yet unidentified stress antigen (156, 157, 159). DETC rapidly become activated in a TCR dependent-manner and their activation is associated with retraction of their dendrites and cellular rounding (54, 155, 159). Full activation of DETC in this context requires engagement of the TCR and costimulation provided by the junctional adhesion molecule JAML (81), CD100 (semaphorin-4D) (160) or NKG2D (161, 162), whose ligands are all upregulated in damaged skin. Activated DETC provide anti-apoptotic signals to keratinocytes and promote their survival through the production of insulin-like growth factor-1 (84). DETC also produce many additional growth factors, including keratinocyte growth factor (KGF)-1 and KGF-2 (54, 83), inflammatory cytokines like IFNγ and TNFα (81, 163) and chemokines (164) that favor epithelial regeneration and wound closure. The important and non-redundant contribution of DETC to wound repair was demonstrated in Tcrd^−/− mice or animals deficient in DETC costimulatory signals. Lack of DETC or their impaired activation led to a substantially delayed wound healing (54, 81, 160–162). Additional roles of DETC include regulation of aberrant inflammation in a model of contact dermatitis (55) and protection against UV-mediated DNA damage (165), cutaneous infection (56) and development of malignancies (57, 58, 166). Interestingly, DETC may mediate their anti-cancer effect by direct cytolytic activity in a TCR- and NKG2D-dependent manner in vitro (57). Additionally, IL-13 production by DETC favors the production of IgE (158), that promotes protective anti-cancer immunity through a yet undetermined mechanism involving tumor infiltrating FcεRI⁺ cells (166).

Mucosal and epithelial sites are not only patrolled by natural resident cells like DETC, they are also kept under the surveillance of pathogen-induced CD8⁺ and CD4⁺ αβ T_RM cells which provide local long-lived protection against reinfection (7, 8). Natural and induced resident T cells occupy a similar space. Cutaneous infection by herpes simplex virus (HSV) generates CD8⁺ T_RM that remain in the basal epidermis around the lesion site (167, 168). Surprisingly, the increased CD8⁺ T_RM density at the site of infection inversely correlated with DETC numbers even several months after pathogen clearance. Conversely, distant DETC-rich areas had a reduced CD8⁺ T_RM population. One potential explanation for the redistribution of resident T cell subsets is that infection may lead to selective loss of DETC, creating a niche for CD8⁺ T_RM cell seeding. Indeed, DETC are rapidly infected by HSV after cutaneous exposure (169). HSV infection of non-neuronal cells is typically lytic and may induce their death. However, alternative mechanisms may also lead to loss of DETC as their redistribution was also observed after intradermal injection of effector CD8⁺ T cells in the absence of infection (168). DETC can also be temporarily displaced by infiltrating NKT cells following acute stress (58), demonstrating that conventional and unconventional αβ T cells can colonize the skin and create a niche at the expense of DETC. It has been proposed that these cells may compete for maintenance signals like IL-15 or aryl hydrocarbon receptor (AhR) ligands (170), which are necessary for mature DETC survival in the skin (171–174). Such competition should also occur between αβ T_RM generated by different, non-overlapping infections as both populations would be expected to have similar homeostatic requirements. However, it was recently reported that the generation of new αβ T_RM cells does not result in the replacement of previously established T_RM cells (175), suggesting that limited resources like IL-15 may not be responsible for redistribution of DETC and αβ T_RM cells. Identifying the factors involved in the maintenance of natural and induced T cell populations is necessary to better understand their apparent competition and would be beneficial for the design of targeted local therapies.

Intestinal intraepithelial lymphocytes–γδ IEL

The intestinal epithelium is actively patrolled by IEL, a large fraction of which are unconventional γδ T cells expressing a CD8αα homodimer in mice (19, 176). The intestine is colonized by γδ IEL during the perinatal period. In contrast to the essential role of the thymus in the generation other γδ T cell subsets, its contribution to intestinal γδ IEL development is more limited. Intestinal γδ IEL can develop extrathymically in athymic mice but at lower numbers than in euthymic animals (177–180). IL-7 production has been shown to be fundamental for γδ IEL thymic and extrathymic intestinal development (181, 182). A large fraction of γδ IEL express the Vγ5 TCR (79, 183). The preferential expression of Vγ5 is controlled at the chromatin level by IL-15-STAT5 signals, which regulate the accessibility of the Vγ5 gene and favor its expression in thymocytes and immature IEL (184). Despite the overrepresentation of the Vγ5 TCR among γδ IEL, the overall γδTCR repertoire in the intestinal epithelium is diverse. Indeed, several mechanisms contribute to the diversity of intestinal γδ IEL including various Vδ and Vγ chain pairings, usage of the Jδ1 or Jδ2 segment and addition of non-germline encoded nucleotides (79, 183). Because of their TCR heterogeneity, γδ IEL have the potential to recognize a wide array of potential antigens or ligands that include host-derived molecules such as nonclassical and nonpolymorphic MHC class Ib molecules T10 and T22 (185). Despite the similarity to MHC class I molecules, T10 and T22 do not present peptide antigens. T10/T22 reactivity is conferred by a specific W-(S)EGYEL CDR3δ motif, which allows some Vγ5⁺, Vγ1.1⁺ and Vγ2⁺ γδ IEL to bind T10/T22 (185). To date, the antigenic specificity of the non-T10/T22 reactive γδ IEL remains obscure.

γδ IEL precursors do not require S1P1 for their emigration from the thymus (186). However, γδ thymocytes and unconventional (CD8αα⁺) recent thymic emigrants express high levels of the gut homing receptors CCR9 (187, 188) and α₄β₇ integrin (187–189). Interestingly, CCR9 is preferentially expressed by antigen-inexperienced CD122^lo or CD62L^hi CD44^int/lo thymocytes (189, 190), suggesting they have more potential to home to the gut and that some γδ IEL did not encounter their antigen prior to their migration into intestinal tissues. This assumption was confirmed by the presence of similar numbers of T10/T22 reactive γδ T cells in the intestinal epithelium of B2m^−/− mice, which lack surface expression of T10/T22 (190). Intestinal γδ IEL might be selected based on their TCR affinity more than their specificity, as suggested by the inverse correlation between TCR affinity and CCR9 expression (190). This unusual “non-selection” of a diversified γδ T cells likely reflects the need to maintain a heterogeneous broadly reactive population that can respond appropriately to the wide variety of stresses and antigens encountered in the intestine.

Within the first few weeks of life, Vγ5⁺ T cells expand in the intestinal epithelium and transition from an immature to a mature phenotype (180). Despite the heavy microbial colonization of the gut, γδ IEL expansion and maturation are independent of the microbiota (66, 178). Instead, expansion and maturation are regulated in a TCR-dependent manner by the BTN-like (Btnl)1 and Btnl6 heterocomplex expressed on the surface of enterocytes (180), reminiscent of Skint-1-mediated selection of DETC in the thymus (144–146). Upon selection by cells co-expressing Btnl1 and Btnl6, Vγ5⁺ T cells upregulate CD25 and produce pro-inflammatory cytokines like IFNγ, growth factors like GM-CSF and chemokines like CCL4 (180). The Btnl-mediated selection of intestinal γδ IEL may occur in a similar fashion in humans, with Vγ4⁺ T cells being activated by cells co-expressing BTNL3 and 8 (180). Once established in the tissue, γδ IEL rely on the production of IL-15 by microbiota stimulated intestinal epithelial cell (IEC) (191–193) and AhR ligands (174) for their maintenance and survival. In return, γδ T cells participate in the maintenance of tissue homeostasis and barrier integrity. γδ IEL promote IEC proliferation and maturation through multiple mechanisms that may include production of KGF (83, 129, 141), regulating tight junctions (67), producing anti-microbial peptides in response to pathobiont invasion (68), limiting tissue damage, and promoting epithelial repair after injury (141).

γδ IEL from specific pathogen-free (SPF) mice constitutively express cytotoxic genes, including granzyme A and B (194), and can lyse target cells directly ex vivo (195), consistent with an anti-infectious role of intestinal γδ IEL. The absence of γδ T cells in Tcrd^−/− was associated with enhanced dissemination of enteric bacteria (Salmonella enterica serovar Typhimurium) or parasites (Toxoplasma gondii), rendering mice more susceptible to systemic infection (67–69). Additionally, γδ IEL indirectly protect from murine norovirus infection by secreting type I and III interferons and increasing the resistance of IEC to viral infection (196). They are also important in controlling dissemination of commensals that may occur with loss of barrier integrity after pathogen invasion or epithelial injury (197). Thus, γδ IEL serve multiple functions in regulating immunity at the mucosal interface with the environment.

Intestinal γδ IEL were initially thought to have limited mobility within the epithelium (188). This view has recently been challenged by two compelling studies that demonstrated that intestinal γδ IEL are highly dynamic and constantly migrate within the intestinal tissue. During tissue homeostasis, individual γδ IEL survey a large surface area and contact numerous IEC within a short period of time (66, 198). γδ IEL mainly remain in the middle region of the intestinal villi, between the basement membrane and the epithelial layer, but they also appear to occasionally migrate to the intercellular space between IEC for a short period of time (66, 198). Although commensals do not impact γδ IEL numbers, microbial colonization is required for their normal distribution within the villi and their migratory behavior in the tissue (66), and also promotes their cytotoxic and anti-microbial functions (68, 195). These patterns drastically change upon enteric infection with invasive bacteria or parasites. Shortly after pathogenic exposure, γδ IEL preferentially localized to pathogen-rich areas and decreased their normal surveillance behavior. Reduced surveillance coverage was associated with increased movement between IEC and the lateral intercellular space in a behavior termed “flossing” (66, 69) that is regulated by the tight junction protein occludin (198). These behavioral and functional changes result from the MyD88-dependent sensing of pathogenic microbes by IEC, and the specific abrogation of MyD88 signaling in IEC severely blunted γδ IEL responses (66, 68). γδ IEL at steady-state may also be activated through their TCR as injection of a TCRδ-specific antibody diminished intracellular calcium flux (199). It is therefore conceivable that the IEC-γδ IEL dialogue could also involve TCR-mediated tissue surveillance. Thus, γδ IEL continually survey epithelial integrity via cross-talk with IEC which dictates γδ IEL behavior and leads to their adaptation in the intestinal environment. While the exact function of γδ IEL flossing remains unclear, its association with pathogen hotspots and the importance of γδ T cell responses to anti-infection immunity suggests an important role of flossing in controlling intestinal infections or promoting epithelial repair.

Natural tissue-resident γδ T cells are remarkably adapted to their tissue of residence, where they provide signals necessary to maintain tissue homeostasis and barrier integrity while also providing a rapid front-line defense against infectious assaults continually encountered in epithelial tissues. Both DETC and intestinal γδ IEL are adapted to efficiently survey their respective tissues, through their placement/migration into the tissue and communication with neighboring epithelial and immune cells. Despite this, natural tissue-resident T cells may have to compete for limited space or nutrients with de novo generated conventional T_RM cells after local infections. Whether direct competition for resources and space or an undefined crosstalk between these cells regulate tissue colonization is unclear and an area of much interest.

Microbiota-induced γδ17 T cells: diversified effectors with multifaceted roles

Almost all tissues exposed to the environment are colonized by established commensal communities, with the exception of the eye for which the presence of a resident microbiome remains a matter of debate (1). The presence of these microorganisms shapes the local immune system and promotes protective anti-infectious immunity, as exemplified by the anti-bacterial, -fungal or -parasitic type-17 and type-1 responses triggered by segmented filamentous bacteria in the intestines (2) or Staphylococcus epidermidis (S. epidermidis) and other commensals in the skin (3, 4), respectively. However, commensal-specific T cells (especially intestinal T_H17 cells) can also have detrimental effects at remote sites under certain circumstances, inducing pathological inflammatory responses that lead to the development of diseases like arthritis and autoimmune encephalomyelitis (5, 6).

As for conventional T cells, the microbiota also impacts γδ T cell responses at many body sites. Interestingly, commensal-induced γδ T cell responses appear to largely involve IL-17A-producing cells regardless of their tissue distribution among diverse sites such as the skin (4, 200), the liver (22), the oral and peritoneal cavities (23, 201), the eye (24), the lungs (28) and the intestines (29, 197). The generation and activation requirements of microbiota-induced γδ T cells appear uniquely adapted to the tissue location. First of all, the presence of a microbiota is a prerequisite for the development of some, but not all, tissue tropic γδ T cells. Indeed, antibiotic-treated SPF or germ-free (GF) mice harbor fewer activated liver-resident (22), pulmonary (28), peritoneal, and small intestinal lamina propria (siLP) γδ17 T cells (23). In contrast, γδ IEL numbers are independent of a microbiota (66, 178, 197). Second, few identified microorganisms have been specifically associated to particular γδ T cell populations: Corynebacterium mastidis (C. mastidis) colonization with ocular Vγ2⁺ γδ17 T cells (24), Corynebacterium accolens (C. accolens) and other bacteria from the Corynebacterium genus producing mycolic acid with skin Vγ2⁺ γδ17 T cells, and S. epidermidis with skin Vγ2⁻ γδ17 T cells (200). The expansion of Vγ2⁺ and Vγ2⁻ γδ T cell subsets by C. accolens and S. epidermidis association, respectively, demonstrates that the γδ T cell responses can adapt within the same niche. In contrast, other γδ T cell subsets only require the presence of a microbiota without any distinction between bacterial species (22, 28). Lastly, many different signals control the activation and/or expansion of commensal-induced γδ17 T cells, including lipid presentation by the non-classical molecule CD1d (22), DC-mediated expansion (24, 201) and activation/polarization (27, 29, 200) or MyD88 signaling pathways (23, 197). Cytokines like IL-1β (23, 24), IL-23 (200) and IL-6 (28), either alone or in combination with other activation signals, also participate in the induction or propagation of IL-17A from microbiota-induced γδ T cells.

IL-17 family cytokines, including IL-17A, are key regulators of mucosal and epithelial immunity. Over the past decade, a multitude of roles, from the induction of protective anti-infectious responses to the promotion of pathological inflammatory processes, have been attributed to IL-17A (202). Accordingly, the induction of γδ17 T cells by microbial colonization has also been associated with seemingly contrasting effects. Commensal-induced γδ T cells can mediate local protection against penetrating commensals (197), pathogenic bacteria or even yeast, as exemplified by the resistance displayed by C. mastidis colonized animals to ocular Candida albicans infection (24). In this model, induced γδ T cells were driving the production of antimicrobial peptides such as S100A8 and S100A9 and the recruitment of neutrophils through the production of IL-17A. As IL-17A can elicit these responses in virtually all mucosal and epithelial surfaces, similar broad-spectrum anti-infectious immunity might occur in other γδ T cell rich tissues. In contrast to their protective effect against infection, microbiota-elicited γδ17 T cells may be beneficial (28) or harmful (29) in cancer. Other local detrimental effects attributed to microbiota-induced γδ17 T cells include the acceleration of nonalcoholic fatty liver disease by liver-resident γδ17 T cells (22) and the exacerbation of imiquimod-induced skin inflammation following C. accolens association (200).

Microbiota-elicited γδ T cells can also impact distal immune function. They express a plethora of homing receptors that allows them to navigate to distant tissues and impact health or disease. For example, γδ T cells are recruited to the ischemic penumbra after ischemic stroke in a CCR6-dependent manner (203). There, they contribute to exacerbate brain injury through the production of IL-17A and subsequent recruitment of neutrophils (203–205). In a recent study using a transient middle cerebral artery occlusion mouse model, the γδ17 T cells recruited to the ischemic brain originated from the small intestine and were dependent on specific commensal species for their maintenance (27). Alteration of the gut microbiota by antibiotic treatment led to a reduction in intestinal γδ17 T cells and diminished γδ T cell infiltration to the meninges, limiting injury. Thus, commensal-induced γδ T cells may have local and distal effects on pathological or physiological tissue processes.

It is now well established that the microbiota is a critical component of human health and disease. In addition to providing many enzymatic and metabolic pathways and colonization resistance to invading pathogens, commensals also participate in the development of and shaping of the immune system (206). Dysbiosis can be sensed by the immune system and has been associated with the development or exacerbation of many diseases in many organ systems. Given their preferential association with epithelial and mucosal tissues, it is not surprising that some γδ T cell populations are also influenced by the microbiota.

Inflammatory disease and memory-like γδ17 T cell response

In addition to γδ T cell responses to the microbiota or after infection, γδ T cells have also been implicated in innate responses in inflammatory disease. Inflammatory diseases with γδ T cell contributions include multiple sclerosis or EAE (72), psoriasis (135), collagen induced arthritis (73), ankylosing spondylitis (74), inflammatory bowel disease (63, 64), and uveitis (75). One factor of inflammatory disease progression attributed to γδ T cells is IL-17A production, a feature often associated with changes in the microbiota (72, 73, 135). Inflammation-induced tissue damage may allow bacteria to bypass the epithelium leading to a positive feedback inflammatory loop. Interestingly, memory-like γδ T cell formation has been seen in inflammation of the skin (25, 26, 51, 207). IL-17A-producing Vγ2Vδ4⁺ T cells initially derive from the neonatal thymus where they are instructed with tissue tropism. IMQ-induced psoriasis-like skin inflammation triggers a potent long-lived Vγ2Vδ4⁺ T cell response (Figure 1) (25, 26). These Vγ2Vδ4⁺ T cells were phenotypically memory-like with a CD44^hi CD62L^lo CD27⁻ expression pattern. Vγ2Vδ4⁺ T cells expanded after primary challenge and migrated from the draining lymph nodes to both the inflamed and uninflamed skin in a S1P1-dependent manner where they persisted. Migration of Vγ2Vδ4⁺ T cells from the circulation to the skin may also be influenced by signals including cutaneous lymphocyte antigen (CLA) binding to P- and E-selectins, CD103 interactions with E-cadherin, and C-C chemokine receptor type 2 (CCR2), and CCR6. CCR2 appeared essential for γδ17 T cell recruitment to inflamed tissues in B16 melanomas and EAE while CCR6 appeared necessary for dermal γδ17 T cell residence (208). Subsequent IMQ administration on previously untreated skin induced an accelerated and robust re-expansion of skin resident Vγ2Vδ4⁺ T cells that produced IL-17A/F and exacerbated disease (25, 26). IL-17 production and subsequent neutrophil recruitment for skin disease appeared be partially dependent on an NFκB-inducing kinase (207). Enhanced inflammation with subsequent exposure was also associated with the Vγ2Vδ4⁺ T cell recall response but independent of αβ T cells (26). These findings were also noted in an acute contact dermatitis model using dinitrofluorobenzene where a similar memory Vγ2⁺ γδ17 T cell population appeared predominately tissue-resident in classical parabiosis experiments (51). Together, these studies suggest that γδ T cells can modulate inflammatory diseases of the skin by forming long-lived tissue resident memory populations that exacerbate disease through the production of IL-17 family cytokines. While these studies suggest the establishment of long-lived memory T cells, whether this response is driven by a specific antigenic responsiveness or is broadly reactive is unclear.

Figure 1

Infection-induced adaptive γδ T cells: long-term players in mucosal immunity

Anamnestic immunity was thought to be mediated solely by conventional αβ T cells and B cells. The recent identification of several innate and unconventional memory responses challenged this belief and has reshaped our view of immunological memory. γδ T cells bridge innate and adaptive immunity in many contexts by rapidly responding to stresses such as infections and promoting conventional adaptive immunity. For that reason, most mouse studies focused on γδ T cell responses in the first few hours to days after pathogen exposure or inflammatory insult. However, mounting evidence in humans, non-human primates and mice demonstrated that γδ T cells can mount adaptive-like responses. One of the most studied pathogens in that context is CMV. Indeed, the involvement of γδ T cells in the protective response to CMV infection was first suggested in kidney transplant patients whose γδ T cells underwent a massive and long-lasting expansion in the blood (34, 209, 210). γδ T cell expansion to CMV was also observed in the context of immunosuppression or immunodeficiency (35, 36, 126, 211–215), neonatal infection (216) and in otherwise healthy individuals (35, 125). Analysis of the repertoire of CMV-selected γδ T cells revealed an oligoclonal and in some individuals even monoclonal population (34, 35, 125), which, surprisingly, did not involve circulating Vγ9Vδ2⁺ T cells but tissue tropic Vδ2⁻ γδ T cells. Expanded cells displayed a T_EMRA phenotype, similar to CMV-specific CD8⁺ T cells (127), and only responded to CMV infection (34, 128). Importantly, the expansion of Vδ2⁻ γδ T cells correlated with the resolution of the acute infection in humans (210) and adoptive transfer of murine CMV-expanded γδ T cells conferred full protection to susceptible immunodeficient mice (217, 218). Thus, CMV-elicited γδ T cells display many features classically attributed to conventional memory T cells. Another long-lived γδ T cell response to virus has been reported in the context of vaccinia virus immunization in humans (38) and rhesus macaques (39). Interestingly, vaccinia virus immunized macaques were protected against monkeypox virus challenge infection and this was associated with the expansion of circulating and pulmonary Vγ9Vδ2⁺ T cells. Long-lasting adaptive-like γδ T responses were also reported in the circulation of individuals infected with the protozoan Plasmodium falciparum (P. falciparum) (40–43) and the circulation and peripheral tissues of animals infected with Plasmodium chabaudi (44). Interestingly, γδ T cell distribution to parasite-targeted tissues raises the possibility that these cells might provide unique functions to control parasite replication during the blood and liver stages. Collectively, these studies provide compelling evidence of adaptive γδ T cell responses triggered by unrelated pathogens in humans, non-human primates and rodents. However, the chronic or latent nature of the infections and their associated antigen and inflammation in conjunction with some inherent challenges associated with human studies has hindered conclusive demonstrations of the memory potential and long-term tissue residency of these populations.

Infection-induced bona fide memory γδ T cell responses

Adaptive γδ T cells survey exposed mucosal and epithelial barriers where they may participate in pathogen clearance or control and have tissue-adapted functions. γδ T cells are one of the first immune responders in many bacterial infections, where they act concurrently with cells of the innate immune system. However, this innate γδ T cell response does not preclude the establishment of a subsequent localized memory γδ T cell response. A mouse model of peritonitis induced by repeated intraperitoneal exposure to Staphylococcus aureus (S. aureus), induced a rapid Vγ1.1⁺ and Vγ2⁺ γδ17 T cell response in the peritoneum and the draining mediastinal lymph nodes a few hours after exposure (49). After this early polyclonal innate response, a long-lived predominantly IL-17A-producing Vγ4⁺ T cell population emerged in both tissues. Surprisingly, secondary challenge with S. aureus of previously exposed but pathogen-free mice induced a conventional memory response of Vγ4⁺ T cells. Recalled Vγ4⁺ T cells underwent secondary expansion, displayed an activated CD44^hi CD27⁻ phenotype, and produced elevated levels of IL-17A. Adoptive transfer of purified S. aureus-elicited Vγ4⁺ T cells was sufficient to protect naïve recipients against peritonitis and bacterial dissemination to the liver and kidneys (49). In contrast to the fundamental role of IL-1β in the induction of IL-17A production by naive γδ T cells during primary S. aureus exposure, memory Vγ4⁺ T cells were IL-1β-independent suggesting that memory γδ T cells have an altered ability to respond to unique environmental cues to provide effector functions. Localized S. aureus infection of the skin in Il1b^−/− mice resulted in poor bacterial control during primary infection but protection against reinfection, revealing the potential presence of an additional memory γδ T cell subset. Indeed, intradermal infection induced the selective expansion of skin resident Vγ4Vδ1⁺ and Vγ3Vδ1⁺ T cell clones with conserved CDR3δ and CDR3γ motifs that were maintained during the convalescent phase and present after secondary infection of WT and Il1b^−/− mice (50). Protection during secondary infection was conferred by IFNγ- and TNFα-producing γδ T cells. Adoptive transfer of purified S. aureus-elicited γδ T cells, but not CD4⁺ T cells, neutrophils or serum from convalescent mice, was associated with bacterial clearance. Thus, different memory γδ T cell responses can be induced by the same pathogen and local memory γδ T cell populations may be tissue adapted to provide distinct protective mechanisms.

In addition to the memory responses involving Vγ4⁺ T cells, a long-lasting protective response of Vγ2⁺ T cells was observed after pulmonary Bordetella pertussis (B. pertussis) infection (Figure 2) (48). After an early innate response dominated by IL-17A-producing Vγ1.1⁻ Vγ2⁻ γδ T cells, effector memory CD44⁺ CD27⁻ Vγ2⁺ T cells started accumulating from day 14 and were maintained long-term in the lungs. The later emergence of Vγ2⁺ T cells coincided with the expansion of T_RM precursors and T_EM-like CD4⁺ T cells in the lungs (219). Expanded pulmonary Vγ2⁺ T cells share several features with B. pertussis-specific memory CD4 T cells: (i) they reside in the lungs for a prolonged period of time after bacterial clearance and rapidly and locally proliferated in response to secondary pulmonary challenge, (ii) a considerable fraction expresses the T_RM marker CD69 and some also co-express CD103, (iii) they have a strict reactivity to B. pertussis, (iv) they are biased toward IL-17A production, and (v) they contribute to enhanced bacterial clearance after challenge (48, 219). Thus, B. pertussis-elicited memory γδ T cells closely resemble conventional T_RM cells. In contrast to the reported displacement of skin DETC by virus-specific CD8⁺ T_RM (168), CD4⁺ T_RM and memory γδ T cells were able to coexist in the lungs of infected mice and both subsets expanded after infection and participated in conferring protection, suggesting that they may reside in distinct niches within the tissue or do not compete for space or survival factors.

Figure 2

Microorganisms producing PAgs are potent activators of human and non-human primate Vγ9Vδ2⁺ T cells. Mycobacteria, including Mycobacterium bovis BCG strain and Mycobacterium tuberculosis (M. tuberculosis), produce HMBPP (220–222), the most potent Vγ9Vδ2⁺ T cell activator. Correspondingly, intravenous (i.v.) BCG vaccination of macaques triggered a drastic expansion of these circulating cells in the blood, but also in the lungs and the intestines (45). Pulmonary M. tuberculosis infection led to a similar expansion of mucosal but not circulating Vγ9Vδ2⁺ T cells (47), demonstrating tissue-adapted responses by adaptive γδ T cells that may be predicated on immunization route. BCG challenge of vaccinated monkeys induced a more rapid and robust clonal expansion of Vγ9Vδ2⁺ T cells but no other γδ T cell subsets. Thus, Vγ9Vδ2⁺ T cells are capable of forming long-lived clonally-expanded memory responses (45). Interestingly, direct contact with antigen presenting cells was required for the recall-like expansion of Vγ9Vδ2⁺ T cells (46). The recall response of Vγ9Vδ2⁺ T cells in BCG immunized macaques was associated with enhanced clearance of challenge infection and protection against fatal tuberculosis (45). In line with these findings, Vγ9Vδ2⁺ T cells induced in BCG vaccinated volunteers that were previously unexposed to any mycobacteria showed an enhanced responsiveness to M. tuberculosis ex vivo (223), suggesting that BCG vaccination also primes γδ T cells to respond to M. tuberculosis in humans. Although human and monkey Vγ9Vδ2⁺ T cells share many features, including a memory-like response to mycobacteria, it remains to be established whether human γδ T cells, like their non-human primate counterparts, are maintained in peripheral tissues following BCG immunization to confer some protection against M. tuberculosis infection.

Multifunctional memory γδ T cells to L. monocytogenes

L. monocytogenes is known to be a potent inducer of γδ T cell responses. In humans, expansion of Vγ9Vδ2⁺ T cells has been detected in the blood of pregnant women, newborns, infants and the elderly early after L. monocytogenes exposure (224, 225). These γδ T cells displayed an activated (HLA-DR⁺) and memory (CD45RO⁺) phenotype. Consistent with a predetermined innate response, stimulation of PBMC from healthy donors with heat-killed L. monocytogenes (225), listeria lysate or culture supernatant (226) led to rapid proliferation of Vγ9Vδ2⁺ T cells.

A similar mobilization of circulating γδ T cells during L. monocytogenes infection has also been reported in rhesus macaques. In a model of disseminated L. monocytogenes infection, Vγ9Vδ2⁺ T cells increased in the blood of rhesus macaques infected with an attenuated L. monocytogenes strain through an intramuscular, and to a lesser extent i.v. route (59). These cells were also elevated in bronchoalveolar lavages and rectal biopsies suggesting that they actively traffic to and seed mucosal tissues during infection. More interestingly, L. monocytogenes challenge of immunized animals led to a rapid and robust re-expansion of Vγ9Vδ2⁺ T cells that correlated with the resolution of infection (59). One peculiar feature of L. monocytogenes is its ability to use both the classical mevalonate and the alternative MEP pathways for isoprenoid synthesis (227). Both primary and recall-like responses of Vγ9Vδ2⁺ T cells have been shown to rely on the bacteria's ability to co-produce mevalonate-derived isopentenyl pyrophosphate and MEP-derived HMBPP, the latter being much more efficient at inducing primary and secondary expansion of primate Vγ9Vδ2⁺ T cells and promoting their differentiation into CD27⁺ CD45RA⁻ CD28⁻ memory cells (60). L. monocytogenes-elicited γδ T cells displayed various effector functions after secondary challenge, including production of IFNγ, IL-4, IL-17A, and TNFα (59). Surprisingly, a substantial portion of these cells were multifunctional and simultaneously produced IFNγ and IL-17A, IFNγ and IL-4, or TNFα and perforin in response to HMBPP (59, 60). Expanded Vγ9Vδ2⁺ T cells were also potent bactericidal effectors capable of efficiently lysing L. monocytogenes-infected DC and restraining intracellular bacterial growth in macrophages ex vivo. Thus, L. monocytogenes infection elicits a multifunctional circulating γδ T cell response in non-human primates. Because this response is accompanied by the colonization of epithelial tissues, infection-elicited mucosal γδ T cells may also have distinct effector functions that provide tissue-adapted responses.

A large body of evidence has convincingly demonstrated the involvement of γδ T cells in the early phase of the primary immune response to systemic L. monocytogenes infection of mice (228–244) and rats (245, 246). More recently, our group reported a bona fide memory γδ T cell response in mice after food-borne infection with a mouse-adapted L. monocytogenes capable of intestinal epithelial cell invasion (Figure 3) (62, 134, 247). Food-borne infection induced a long-lived Vγ4Vδ1⁺ T cell population in the gut draining mesenteric lymph node (MLN) with a CD44^hi CD27⁻ phenotype (62). By 7 days after infection, these cells were mobilized into the blood, up-regulated the gut-homing integrin α₄β₇ and trafficked to the intestinal lamina propria similarly to conventional L. monocytogenes-specific CD8⁺ (248) and CD4⁺ (249) αβ T cells. Like L. monocytogenes-induced CD4⁺ and CD8⁺ αβ T_RM cells, L. monocytogenes-elicited γδ T cells established residency in MLN and intestinal lamina propria where they were maintained long term in the absence of further antigenic stimulation (62, 134). The generation of this γδ T cell subset was restricted to tissues associated with the gastrointestinal system and was induced by food-borne (62) but not i.v. infection (232, 233). L. monocytogenes-elicited γδ T cells demonstrated enhanced anamnestic response upon L. monocytogenes challenge infection and were fully competent for immunologic boosting upon tertiary exposure (62). Although L. monocytogenes-elicited γδ T cells appeared to share a similar anatomical niche as L. monocytogenes-specific CD4⁺ and CD8⁺ αβ T cells (248, 249), all populations expanded robustly after infection and were maintained without any apparent competition for limiting resources or anatomic space.

Figure 3

Memory γδ T cells cooperated with αβ T cells to confer optimal protection in the MLN and the small intestine during food-borne L. monocytogenes challenge infection. Indeed, only the concomitant antibody-mediated depletion of αβ T cells (both CD8⁺ and CD4⁺) and forced internalization of the γδ TCR resulted in the complete loss of protection afforded to immunized mice, whereas the sole removal of αβ T cells only partially impaired L. monocytogenes control (62). One striking feature of L. monocytogenes-elicited γδ T cells was their ability to produce IFNγ and IL-17A during each stage of the immune response. Moreover, subsets within the CD44^hi CD27⁻ γδ T cell population co-produced both cytokines during the primary and secondary responses (62), reminiscent of the multifunctional response described in rhesus macaques after secondary challenge (59). During the recall response, the majority of IL-17A was derived from reactivated memory γδ T cells in the MLN. This production of IL-17A was a critical component of anti-listerial immunity as it mediated the formation of L. monocytogenes-containing immune cell clusters composed of memory γδ T cells and IL-17RA⁺ inflammatory monocytes and neutrophils (134).

Collectively, these studies demonstrate that systemic and food-borne L. monocytogenes infection generates long-lived multifunctional memory γδ T cells in rhesus macaques and mice, respectively. Thus, a population of pathogen-elicited γδ T cells appears to behave very similarly between mice and primates, and this may suggest a conserved biology among mucosal γδ T cells. These studies also highlight the important influence of infection route and models that mimic natural infection on understanding the γδ T cell response. Interestingly, amongst the memory and memory-like responses described to date, L. monocytogenes is the only agent known to induce multifunctional γδ T cells in two distinct species. Although γδ17 T cells are known to have a permissive chromatin state for IFNγ expression (102), other memory γδ T cell populations reported in mice only produce IL-17A (25, 26, 48, 49). Conversely, only IFNγ was shown to be produced by virus-activated memory-like Vγ9Vδ2⁺ T cells (39). miR-146a has recently been shown to negatively regulate IFNγ production by murine γδ17 T cells, including during oral L. monocytogenes infection (61). Elucidating the mechanisms by which L. monocytogenes partially breaks miR-146a-mediated inhibition of IFNγ production by γδ17 T cells and understanding why other pathogens do not would provide important clues about the fine regulation of γδ17 T cell functions and might open new avenues for the manipulation of these cells.

Anti-tumor memory γδ T cells in cancer

A substantial body of research has focused on the beneficial nature of γδ T cells in anti-cancer immunity and their potential as a targetable therapeutic since a landmark study demonstrated that γδ T cells in the epithelial compartment play a substantial role in prevention of cutaneous carcinogenesis (57). Indeed, the presence of an intra-tumoral γδ T cell gene signature was associated with the single most favorable prognostic indicator of patient outcome for a wide range of cancers (250). γδ T cells can have a wide range of effects ranging from reshaping the tumor microenvironment (251, 252), being integral in promoting a diverse cancer protective IgE repertoire through NKG2D stress surveillance (166), or IFNγ production (52). Substantial effort has focused on resolving the anti-tumor activity of Vγ9Vδ2⁺ T cells, the predominant γδ T cell population in human PBMC, in multiple cancers (253–257). Tissue resident Vδ2⁻ γδ T cells may also substantially contribute to anti-tumor immunity. Vδ2⁻ γδ T cells typically predominate over Vδ2⁺ T cells within tumors (52, 65) as well as in tissues from healthy individuals (120). This Vδ2⁻ γδ T cell population is principally composed of Vδ1⁺ T cells but also contain a significant population of Vδ3⁺ T cells. Due to Vδ2⁻ γδ T cell prevalence in tumor microenvironment, it is likely that this subset also substantially contributes to anti-tumor activity.

Vγ9Vδ2⁺ T cells were previously delineated based on expression of CD45RA and CD27 as naive (CD45RA⁺ CD27⁺) cells or effector and memory T_CM (CD45RA⁻ CD27⁺), T_EM (CD45RA⁻ CD27⁻), and T_EMRA (CD45RA⁺ CD27⁻) cells (117). While naive T cells and T_CM cells primarily reside in secondary lymphoid tissues, T_EM and T_EMRA migrate to inflammatory sites to perform effector functions. These latter populations have been investigated in multiple cancers including squamous cell carcinoma (SCC) (52), CRC (65), neuroblastoma (71), and melanoma (53) due to their proliferative capacity and tendency to migrate toward inflammatory sites. Substantial effort has also sought to leverage the anti-tumor properties of Vγ9Vδ2⁺ T cells using approaches like in vitro expansion of patient-derived γδ T cells and chimeric antigen receptor T cells for potential adoptive immunotherapies (258, 259). Vγ9Vδ2⁺ T cells can be selectively activated through PAgs or amino bisphosphonates such as zoledronic acid (zoledronate) in combination with various growth factors, cytokines, or costimulatory molecules (260). While various adoptive transfer methods have been primarily explored in a number of pre-clinical studies (261–267), to date, clinically favorable outcomes appear limited to prostate cancer (137). However, challenges remain in the rapid and robust generation of the large numbers of cells that would be necessary for successful adoptive immunotherapies (268). Zoledronate also has various indirect effects on γδ T cells by independently impacting the tumor microenvironment (251, 269, 270), which can provide a pro-tumor or anti-tumor outcome (271, 272). As such, it will be important to assess the contribution of γδ T cells and the impact of any therapies in individual tumor types.

A protective role of tissue resident γδ17 T cells has been readily described in the context of infectious disease, but they have also been implicated in exacerbating chronic inflammatory diseases like psoriasis. Chronic inflammatory disease is a risk factor and clinical precursor to a number of cancers including pancreatic cancer (273), skin cancer (274) and CRC (275). A growing body of literature has also demonstrated a γδ T cell response that promotes tumor growth. This pro-tumor outcome of some γδ T cell responses appears predominately a consequence of IL-17A production that is often associated with the up-regulation of proliferation pathways in cancerous lesions (276) (Figure 4). These apparent anti- and pro-tumor discrepancies are likely due to the dichotomous functional outcomes associated with type-1 or type-17 γδ T cell responses. A pro-tumor role of IL-17A-producing γδ T cells is evident in a number of cancers such as SCC (52), CRC (29), and metastatic breast cancer (70). In human SCC, tumor infiltration of IL-17A-producing Vδ1⁺ and Vδ2⁺ T cells was associated with a negative prognosis, in contrast to a more favorable outcome associated with tumor-infiltrating IFNγ-producing γδ T cells (52). Similar results were seen in human CRC where a predominately Vδ1⁺ IL-17A-producing γδ T cell population positively correlated with a more advanced tumor stage. This correlation was attributed to an inflammatory DC - γδ17 T cell - MDSC regulatory axis (29). Interestingly, tissue resident memory Vγ2⁺ T cells were also seen in a metastatic mouse model of breast cancer. These Vγ2⁺ T cells produced IL-17A and G-CSF, which promoted the establishment of immunosuppressive intratumoral MDSC (70). Collectively, these studies implicate tissue resident Vδ1⁺ and Vγ2⁺ T cells as tumor growth promoting through IL-17A-mediated MDSC recruitment and immunosuppression in cancer. More importantly, these findings segregate deleterious γδ T cell responses from those which may have a beneficial outcome.

Figure 4

On the other hand, Vδ2⁻ γδ T cells are not limited to pro-tumor effects and effort has been invested into their therapeutic benefits. Intrahepatic Vδ1⁺ and Vδ3⁺ T cells express a CD45RA⁺ CD27⁻ and CD45RA⁻ CD27⁻ phenotype that is nearly absent from the blood. Intrahepatic CD45RA⁻ CD27⁻ Vδ1⁺ and Vδ3⁺ T cells were competent producers of IFNγ and TNFα and also expressed receptors for early activation and tissue retention, such as CD69, that have also been noted in both liver resident NK and CD8⁺ αβ T cell populations (120, 277). CMV infection has notably been one of the drivers of hepatic Vδ2⁻ γδ T cell expansion and memory formation, and these factors appear to have a protective effect against tumor formation. CMV-seropositive patients (infected pre- or post-transplantation) have a reduced risk of skin cancer development and leukemia relapse after kidney or bone marrow transplant, respectively (36, 37). Vδ2⁻ γδ T cells from CMV-infected kidney transplant patients were capable of killing HT29 colon cancer cells in vitro (128) and CMV-induced Vδ2⁻ γδ T cells had anti-tumor activity against primary and metastatic tumors in a HT29 xenograft mouse model (278, 279). The characterization of the antigenic specificity of one highly expanded γδ T cell clone from a CMV-seropositive transplant patient revealed that its recognition of stressed (infected or transformed) cells was mediated by the direct binding of the TCR to EPCR, independently of its cargo (33). Similarly, Annexin A2 is upregulated at the surface of stressed cells and can activate another Vδ2⁻ γδ T cell clone (123). However, regardless of which epitope is being recognized, TCR sequencing of intrahepatic Vδ2⁻ γδ T cell populations has revealed that CMV infection can induce expansion, memory phenotypes, and tumor reactivity in a clonally expansive manner (120). Overall, these studies suggest that Vδ2⁻ γδ T cells form T_RM cell populations that can clonally expand and cross-react with tumor epitopes to provide anti-tumor immunity.

Knowledge of resident γδ T cell biology is integral for future cancer therapies. Despite intra-tumoral γδ T cell gene signatures being regarded as a favorable prognostic, there is a delicate balance between becoming pro-tumor and anti-tumor γδ T cells (Figure 4). Pro-tumor populations are characterized by γδ17 T cells and their indirect immunosuppressive activity through MDSC (29). On the other hand, anti-tumor populations are characterized by IFNγ producing γδ T cells (52). Notably, IgE response mediated by DETC stress surveillance can have anti-tumor effects (166) as well as potential autoimmune effects (280). A better understanding of how signals in tumor microenvironment shape and potentially polarize γδ T cell cytokine production and signal to other cells would be of great benefit.

Concluding remarks

The roles of γδ T cells in response to pathogens and commensals and in inflammatory disease and cancer have been an area of expanding interest over the last decade generating significant advances in knowledge. However, our basic understanding of γδ T cell biology is still largely incomplete and lags far behind our understanding of their αβ T cell counterparts, particularly in the area of anamnestic responses. γδ T cells are adapted to their tissue environment which in turn shapes the immune landscape of that environment. Like most cells of the immune system, γδ T cells can appear duplicitous under certain circumstances. On one hand, they can provide beneficial outcomes to the host by conferring anti-pathogen and anti-tumor immunity. On the other hand, they can lead to negative outcomes or exacerbated disease in some inflammatory disorders and cancers. Regardless of their impact, it is now clear that γδ T cell responses encompass both innate inflammatory responses and more traditional adaptive memory responses that provide substantial opportunities for therapeutic targeting. Memory γδ T cell responses may advance a new arm of rationale vaccine design that has broad implications for boosting anti-pathogen or anti-tumor immunity. Vaccines that elicit broadly reactive long-lived circulating or tissue-resident memory γδ T cells may provide protection against a wide range of cancers and infections. Similarly, innate inflammatory or adaptive effector responses may be targeted to enhanced therapeutic modalities with far ranging implications. In the context of a detrimental impact on human health, γδ T cell responses may be blunted or, in the context of cancer, diverted to a lineage that promotes tumor eradication. Thus, memory and tissue-resident γδ T cells represent a lineage of the adaptive immune system that necessitate greater understanding to facilitate the generation of novel therapeutics to promote human health and reduce disease.

References

• 1.

  LeeYKMazmanianSK. Has the microbiota played a critical role in the evolution of the adaptive immune system?Science (2010) 330:1768–73. 10.1126/science.1195568

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2.

  IvanovIIAtarashiKManelNBrodieELShimaTKaraozUet al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 139:485–98. 10.1016/j.cell.2009.09.033

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 3.

  NaikSBouladouxNLinehanJLHanSJHarrisonOJWilhelmCet al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature (2015) 520:104–8. 10.1038/nature14052

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 4.

  NaikSBouladouxNWilhelmCMolloyMJSalcedoRKastenmullerWet al. Compartmentalized control of skin immunity by resident commensals. Science (2012) 337:1115–9. 10.1126/science.1225152

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5.

  WuHJIvanovIIDarceJHattoriKShimaTUmesakiYet al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 32:815–27. 10.1016/j.immuni.2010.06.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 6.

  LeeYKMenezesJSUmesakiYMazmanianSK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. (2011) 108 (Suppl 1):4615–22. 10.1073/pnas.1000082107

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7.

  SchenkelJMMasopustD. Tissue-resident memory T cells. Immunity (2014) 41:886–97. 10.1016/j.immuni.2014.12.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 8.

  MuellerSNMackayLK. Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol. (2016) 16:79–89. 10.1038/nri.2015.3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 9.

  NeteaMGQuintinJvan der MeerJW. Trained immunity: a memory for innate host defense. Cell Host Microbe (2011) 9:355–61. 10.1016/j.chom.2011.04.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 10.

  NeteaMGJoostenLALatzEMillsKHNatoliGStunnenbergHGet al. Trained immunity: A program of innate immune memory in health and disease. Science (2016) 352:aaf1098. 10.1126/science.aaf1098

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 11.

  CerwenkaALanierLL. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. (2016) 16:112–23. 10.1038/nri.2015.9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 12.

  PengHTianZ. Natural Killer Cell Memory: Progress and Implications. Front Immunol. (2017) 8:1143. 10.3389/fimmu.2017.01143

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 13.

  BonnevilleMO'BrienRLBornWK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. (2010) 10:467–78. 10.1038/nri2781

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 14.

  ChienYHMeyerCBonnevilleM. gammadelta T cells: first line of defense and beyond. Annu Rev Immunol. (2014) 32:121–55. 10.1146/annurev-immunol-032713-120216

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15.

  HaydayAC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity (2009) 31:184–96. 10.1016/j.immuni.2009.08.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16.

  ItoharaSFarrAGLafailleJJBonnevilleMTakagakiYHaasWet al. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature (1990) 343:754–7. 10.1038/343754a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17.

  GrayEESuzukiKCysterJG. Cutting edge: Identification of a motile IL-17-producing gammadelta T cell population in the dermis. J Immunol. (2011) 186:6091–5. 10.4049/jimmunol.1100427

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18.

  HavranWLAllisonJP. Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors. Nature (1990) 344:68–70. 10.1038/344068a0.

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19.

  GoodmanTLefrancoisL. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J Exp Med. (1989) 170:1569–81

  • Pubmed Abstract
  • Google Scholar

• 20.

  GarmanRDDohertyPJRauletDH. Diversity, rearrangement, and expression of murine T cell gamma genes. Cell (1986) 45:733–42.

  • Pubmed Abstract
  • Google Scholar

• 21.

  NielsenMMWitherdenDAHavranWL. gammadelta T cells in homeostasis and host defence of epithelial barrier tissues. Nat Rev Immunol. (2017) 17:733–45. 10.1038/nri.2017.101

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 22.

  LiFHaoXChenYBaiLGaoXLianZet al. The microbiota maintain homeostasis of liver-resident gammadeltaT-17 cells in a lipid antigen/CD1d-dependent manner. Nat Commun. (2017) 7:13839. 10.1038/ncomms13839.

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 23.

  DuanJChungHTroyEKasperDL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 7:140–50. 10.1016/j.chom.2010.01.00.

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 24.

  StLeger AJDesaiJVDrummondRAKugadasAAlmaghrabiFSilverPet al. An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal gammadelta T Cells. Immunity (2017) 47:148–58 e5. 10.1016/j.immuni.2017.06.014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25.

  Ramirez-ValleFGrayEECysterJG. Inflammation induces dermal Vgamma4⁺ gammadeltaT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses. Proc Natl Acad Sci USA. (2015) 112:8046–51. 10.1073/pnas.1508990112

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 26.

  HartwigTPantelyushinSCroxfordALKuligPBecherB. Dermal IL-17-producing gammadelta T cells establish long-lived memory in the skin. Eur J Immunol. (2015) 45:3022–33. 10.1002/eji.201545883

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 27.

  BenakisCBreaDCaballeroSFaracoGMooreJMurphyMet al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. (2016) 22:516–23. 10.1038/nm.4068.

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28.

  ChengMQianLShenGBianGXuTXuWet al. Microbiota modulate tumoral immune surveillance in lung through a gammadeltaT17 immune cell-dependent mechanism. Cancer Res. (2014) 74:4030–41. 10.1158/0008-5472.CAN-13-2462

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 29.

  WuPWuDNiCYeJChenWHuGet al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity (2014) 40:785–800. 10.1016/j.immuni.2014.03.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 30.

  LalorSJMcLoughlinRM. Memory gammadelta T Cells-Newly Appreciated Protagonists in Infection and Immunity. Trends Immunol. (2016) 37:690–702. 10.1016/j.it.2016.07.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 31.

  O'BrienRLBornWK. gammadelta T cell subsets: a link between TCR and function?Semin Immunol. (2010) 22:193–8. 10.1016/j.smim.2010.03.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 32.

  NarayanKSylviaKEMalhotraNYinCCMartensGVallerskogTet al. Intrathymic programming of effector fates in three molecularly distinct gammadelta T cell subtypes. Nat Immunol. (2012) 13:511–8. 10.1038/ni.2247

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33.

  WillcoxCRPitardVNetzerSCouziLSalimMSilberzahnTet al. Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor. Nat Immunol. (2012) 13:872–9. 10.1038/ni.2394

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 34.

  DechanetJMervillePLimARetiereCPitardVLafargeXet al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest. (1999) 103:1437–49. 10.1172/JCI5409

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 35.

  KnightAMadrigalAJGraceSSivakumaranJKottaridisPMackinnonSet al. The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood (2010) 116:2164–72. 10.1182/blood-2010-01-255166

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 36.

  ScheperWvan DorpSKerstingSPietersmaFLindemansCHolSet al. gammadeltaT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia. (2013) 27:1328–38. 10.1038/leu.2012.374

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 37.

  CouziLLevaillantYJamaiAPitardVLassalleRMartinKet al. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol. (2010) 21:181–8. 10.1681/ASN.2008101072

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 38.

  AbateGEslickJNewmanFKFreySEBelsheRBMonathTPet al. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. J Infect Dis. (2005) 192:1362–71. 10.1086/444423

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 39.

  ShaoLHuangDWeiHWangRCChenCYShenLet al. Expansion, reexpansion, and recall-like expansion of Vgamma2Vdelta2 T cells in smallpox vaccination and monkeypox virus infection. J Virol. (2009) 83:11959–65. 10.1128/JVI.00689-09

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 40.

  HviidLKurtzhalsJAAdabayeriVLoizonSKempKGokaBQet al. Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun. (2001) 69:3190–6. 10.1128/IAI.69.5.3190-3196.2001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 41.

  HoMTongtawePKriangkumJWimonwattrawateeTPattanapanyasatKBryantLet al. Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect Immun. (1994) 62:855–62.

  • Pubmed Abstract
  • Google Scholar

• 42.

  RoussilhonCAgrapartMGuglielmiPBensussanABrasseurPBalletJJ. Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol. (1994) 95:91–7.

  • Pubmed Abstract
  • Google Scholar

• 43.

  TeirlinckACMcCallMBRoestenbergMScholzenAWoestenenkRde MastQet al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. (2011) 7:e1002389. 10.1371/journal.ppat.1002389

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 44.

  MamedovMRScholzenANairRVCumnockKKenkelJAOliveiraJHMet al. A Macrophage Colony-Stimulating-Factor-Producing gammadelta T Cell Subset Prevents Malarial Parasitemic Recurrence. Immunity (2018) 48:350–63 e7. 10.1016/j.immuni.2018.01.009

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 45.

  ShenYZhouDQiuLLaiXSimonMShenLet al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science (2002) 295:2255–8. 10.1126/science.1068819

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 46.

  ShenHWangYChenCYFrencherJHuangDYangEet al. Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vgamma2Vdelta2 T cells after Mycobacterium tuberculosis infection or vaccination. Eur J Immunol. (2015) 45:442–51. 10.1002/eji.201444635

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 47.

  HuangDShenYQiuLChenCYShenLEstepJet al. Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect Immun. (2008) 76:426–36. 10.1128/IAI.01008-07

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 48.

  MisiakAWilkMMRaverdeauMMillsKH. IL-17-Producing Innate and Pathogen-Specific Tissue Resident Memory gammadelta T Cells Expand in the Lungs of Bordetella pertussis-Infected Mice. J Immunol. (2017) 198:363–74. 10.4049/jimmunol.1601024

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 49.

  MurphyAGO'KeeffeKMLalorSJMaherBMMillsKHMcLoughlinRM. Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection. J Immunol. (2014) 192:3697–708. 10.4049/jimmunol.1303420

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 50.

  DillenCAPinskerBLMarusinaAIMerleevAAFarberONLiuHet al. Clonally expanded gammadelta T cells protect against Staphylococcus aureus skin reinfection. J Clin Invest. (2018) 128:1026–42. 10.1172/JCI96481

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 51.

  JiangXParkCOGeddesSweeney JYooMJGaideOKupperTS. Dermal gammadelta T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity. PLoS ONE (2017) 12:e0169397. 10.1371/journal.pone.0169397

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 52.

  LoPresti EToiaFOieniSBuccheriSTurdoAMangiapaneLRet al. Squamous Cell Tumors Recruit gammadelta T Cells Producing either IL17 or IFNgamma Depending on the Tumor Stage. Cancer Immunol Res. (2017) 5:397–407. 10.1158/2326-6066.CIR-16-0348

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 53.

  CordovaAToiaFLaMendola COrlandoVMeravigliaSRinaldiGet al. Characterization of human gammadelta T lymphocytes infiltrating primary malignant melanomas. PLoS ONE (2012) 7:e49878. 10.1371/journal.pone.0049878

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 54.

  JamesonJUgarteKChenNYachiPFuchsEBoismenuRet al. A role for skin gammadelta T cells in wound repair. Science (2002) 296:747–9. 10.1126/science.1069639

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 55.

  GirardiMLewisJGlusacEFillerRBGengLHaydayACet al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med. (2002) 195:855–67. 10.1084/jem.20012000

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 56.

  ChoJSPietrasEMGarciaNCRamosRIFarzamDMMonroeHRet al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. (2010) 120:1762–73. 10.1172/JCI40891

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 57.

  GirardiMOppenheimDESteeleCRLewisJMGlusacEFillerRet al. Regulation of cutaneous malignancy by gammadelta T cells. Science (2001) 294:605–9. 10.1126/science.1063916

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 58.

  StridJRobertsSJFillerRBLewisJMKwongBYSchperoWet al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol. (2008) 9:146–54. 10.1038/ni1556

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 59.

  Ryan-PayseurBFrencherJShenLChenCYHuangDChenZW. Multieffector-functional immune responses of HMBPP-specific Vgamma2Vdelta2 T cells in nonhuman primates inoculated with Listeria monocytogenes DeltaactA prfA^*. J Immunol. (2012) 189:1285–93. 10.4049/jimmunol.1200641

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 60.

  FrencherJTShenHYanLWilsonJOFreitagNERizzoANet al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vgamma2Vdelta2 T cells. J Leukoc Biol. (2014) 96:957–67. 10.1189/jlb.6HI1213-632R

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 61.

  SchmolkaNPapottoPHRomeroPVAmadoTEnguitaFJAmorimAet al. MicroRNA-146a controls functional plasticity in gammadelta T cells by targeting NOD1. Sci Immunol. (2018) 3:eaao1392. 10.1126/sciimmunol.aao1392

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 62.

  SheridanBSRomagnoliPAPhamQMFuHHAlonzoF3rdSchubertWDet al. gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity (2013) 39:184–95. 10.1016/j.immuni.2013.06.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 63.

  GiacomelliRParzaneseIFrieriGPassacantandoAPizzutoFPimpoTet al. Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease. Clin Exp Immunol. (1994) 98:83–8.

  • Pubmed Abstract
  • Google Scholar

• 64.

  McVayLDLiBBiancanielloRCreightonMABachwichDLichtensteinGet al. Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med. (1997) 3:183–203.

  • Pubmed Abstract
  • Google Scholar

• 65.

  MeravigliaSLoPresti ETosoliniMLaMendola COrlandoVTodaroMet al. Distinctive features of tumor-infiltrating gammadelta T lymphocytes in human colorectal cancer. Oncoimmunology (2017) 6:e1347742. 10.1080/2162402X.2017.1347742

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 66.

  Hoytemavan Konijnenburg DPReisBSPedicordVAFaracheJVictoraGDMucidaD. Intestinal Epithelial and Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection. Cell (2017) 171:783–94 e13. 10.1016/j.cell.2017.08.046

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 67.

  DaltonJECruickshankSMEganCEMearsRNewtonDJAndrewEMet al. Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. Gastroenterology (2006) 131:818–29. 10.1053/j.gastro.2006.06.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 68.

  IsmailASSeversonKMVaishnavaSBehrendtCLYuXBenjaminJLet al. Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci USA. (2011) 108:8743–8. 10.1073/pnas.1019574108

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 69.

  EdelblumKLSinghGOdenwaldMALingarajuAElBissati KMcLeodRet al. gammadelta Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice. Gastroenterology (2015) 148:1417–26. 10.1053/j.gastro.2015.02.053

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 70.

  CoffeltSBKerstenKDoornebalCWWeidenJVrijlandKHauCSet al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature (2015) 522:345–8. 10.1038/nature14282

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 71.

  FisherJPYanMHeuijerjansJCarterLAbolhassaniAFroschJet al. Neuroblastoma killing properties of Vdelta2 and Vdelta2-negative gammadeltaT cells following expansion by artificial antigen-presenting cells. Clin Cancer Res. (2014) 20:5720–32. 10.1158/1078-0432.CCR-13-3464

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 72.

  SuttonCELalorSJSweeneyCMBreretonCFLavelleECMillsKH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity (2009) 31:331–41. 10.1016/j.immuni.2009.08.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 73.

  ItoYUsuiTKobayashiSIguchi-HashimotoMItoHYoshitomiHet al. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. (2009) 60:2294–303. 10.1002/art.24687

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 74.

  KennaTJDavidsonSIDuanRBradburyLAMcFarlaneJSmithMet al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum. (2012) 64:1420–9. 10.1002/art.33507

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 75.

  NianHShaoHO'BrienRLBornWKKaplanHJSunD. Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest Ophthalmol Vis Sci. (2011) 52:5920–7. 10.1167/iovs.10-6758

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 76.

  CardingSRKyesSJenkinsonEJKingstonRBottomlyKOwenJJet al. Developmentally regulated fetal thymic and extrathymic T-cell receptor gamma delta gene expression. Genes Dev. (1990) 4:1304–15.

  • Pubmed Abstract
  • Google Scholar

• 77.

  Munoz-RuizMSumariaNPenningtonDJSilva-SantosB. Thymic Determinants of gammadelta T Cell Differentiation. Trends Immunol. (2017) 38:336–44. 10.1016/j.it.2017.01.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 78.

  PapottoPHRibotJCSilva-SantosB. IL-17(+) gammadelta T cells as kick-starters of inflammation. Nat Immunol. (2017) 18:604–11. 10.1038/ni.3726

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 79.

  AsarnowDMGoodmanTLeFrancoisLAllisonJP. Distinct antigen receptor repertoires of two classes of murine epithelium-associated T cells. Nature (1989) 341:60–2. 10.1038/341060a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 80.

  TurchinovichGHaydayAC. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity (2011) 35:59–68. 10.1016/j.immuni.2011.04.018

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 81.

  WitherdenDAVerdinoPRiederSEGarijoOMillsRETeytonLet al. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science (2010) 329:1205–10. 10.1126/science.1192698

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 82.

  DalessandriTCrawfordGHayesMCastroSeoane RStridJ. IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin. Nat Commun. (2016) 7:12080. 10.1038/ncomms12080

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 83.

  BoismenuRHavranWL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science (1994) 266:1253–5.

  • Pubmed Abstract
  • Google Scholar

• 84.

  SharpLLJamesonJMCauviGHavranWL. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol. (2005) 6:73–9. 10.1038/ni1152

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 85.

  ChienYHZengXPrinzI. The natural and the inducible: interleukin (IL)-17-producing gammadelta T cells. Trends Immunol. (2013) 34:151–4. 10.1016/j.it.2012.11.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 86.

  HaasJDRavensSDuberSSandrockIOberdorferLKashaniEet al. Development of interleukin-17-producing gammadelta T cells is restricted to a functional embryonic wave. Immunity (2012) 37:48–59. 10.1016/j.immuni.2012.06.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 87.

  WenckerMTurchinovichGDi Marco BarrosRDebanLJandkeACopeAet al. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat Immunol. (2014) 15:80–7. 10.1038/ni.2773

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 88.

  MartinBHirotaKCuaDJStockingerBVeldhoenM. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity (2009) 31:321–30. 10.1016/j.immuni.2009.06.020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 89.

  RibotJCChaves-FerreiraMd'OreyFWenckerMGoncalves-SousaNDecalfJet al. Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-gamma- or IL-17-producing gammadelta T cells upon infection. J Immunol. (2010) 185:6421–5. 10.4049/jimmunol.1002283

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 90.

  Barros-MartinsJSchmolkaNFontinhaDPiresde Miranda MSimasJPBrokIet al. Effector gammadelta T Cell Differentiation Relies on Master but Not Auxiliary Th Cell Transcription Factors. J Immunol. (2016) 196:3642–52. 10.4049/jimmunol.1501921

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 91.

  HaasJDGonzalezFHSchmitzSChennupatiVFohseLKremmerEet al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur J Immunol. (2009) 39:3488–97. 10.1002/eji.200939922

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 92.

  KisielowJKopfMKarjalainenK. SCART scavenger receptors identify a novel subset of adult gammadelta T cells. J Immunol. (2008) 181:1710–6. 10.4049/jimmunol.181.3.1710

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 93.

  ShibataKYamadaHNakamuraRSunXItsumiMYoshikaiY. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers. J Immunol. (2008) 181:5940–7. 10.4049/jimmunol.181.9.5940

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 94.

  RibotJCdeBarrosAPangDJNevesJFPeperzakVRobertsSJet al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol. (2009) 10:427–36. 10.1038/ni.1717

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 95.

  JensenKDSuXShinSLiLYoussefSYamasakiSet al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity (2008) 29:90–100. 10.1016/j.immuni.2008.04.022

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 96.

  FahlSPCoffeyFKainLZarinPDunbrackRLJr.TeytonLet al. Role of a selecting ligand in shaping the murine gammadelta-TCR repertoire. Proc Natl Acad Sci USA. (2018) 115:1889–94. 10.1073/pnas.1718328115

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 97.

  CoffeyFLeeSYBuusTBLauritsenJPWongGWJoachimsMLet al. The TCR ligand-inducible expression of CD73 marks gammadelta lineage commitment and a metastable intermediate in effector specification. J Exp Med. (2014) 211:329–43. 10.1084/jem.20131540

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 98.

  Munoz-RuizMRibotJCGrossoARGoncalves-SousaNPamplonaAPenningtonDJet al. TCR signal strength controls thymic differentiation of discrete proinflammatory gammadelta T cell subsets. Nat Immunol. (2016) 17:721–7. 10.1038/ni.3424

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 99.

  SumariaNGrandjeanCLSilva-SantosBPenningtonDJ. Strong TCRgammadelta Signaling Prohibits Thymic Development of IL-17A-Secreting gammadelta T Cells. Cell Rep. (2017) 19:2469–76. 10.1016/j.celrep.2017.05.071

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 100.

  ColpittsSLPuddingtonLLefrancoisL. IL-15 receptor alpha signaling constrains the development of IL-17-producing gammadelta T cells. Proc Natl Acad Sci USA. (2015) 112:9692–7. 10.1073/pnas.1420741112

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 101.

  MichelMLPangDJHaqueSFPotocnikAJPenningtonDJHaydayAC. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing gammadelta cells. Proc Natl Acad Sci USA. (2012) 109:17549–54. 10.1073/pnas.1204327109

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 102.

  SchmolkaNSerreKGrossoARReiMPenningtonDJGomesAQet al. Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory gammadelta T cell subsets. Nat Immunol. (2013) 14:1093–100. 10.1038/ni.2702

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 103.

  ZengXWeiYLHuangJNewellEWYuHKiddBAet al. gammadelta T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response. Immunity (2012) 37:524–34. 10.1016/j.immuni.2012.06.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 104.

  MuschaweckhAPetermannFKornT. IL-1beta and IL-23 Promote Extrathymic Commitment of CD27(+)CD122(-) gammadelta T Cells to gammadeltaT17 Cells. J Immunol. (2017) 199:2668–79. 10.4049/jimmunol.1700287

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 105.

  PapottoPHGoncalves-SousaNSchmolkaNIsepponAMensuradoSStockingerBet al. IL-23 drives differentiation of peripheral gammadelta17 T cells from adult bone marrow-derived precursors. EMBO Rep. (2017) 18:1957–67. 10.15252/embr.201744200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 106.

  McVayLDCardingSRBottomlyKHaydayAC. Regulated expression and structure of T cell receptor gamma/delta transcripts in human thymic ontogeny. EMBO J. (1991) 10:83–91.

  • Pubmed Abstract
  • Google Scholar

• 107.

  McVayLDCardingSR. Extrathymic origin of human gamma delta T cells during fetal development. J Immunol. (1996) 157:2873–82.

  • Pubmed Abstract
  • Google Scholar

• 108.

  ParkerCMGrohVBandHPorcelliSAMoritaCFabbiMet al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med. (1990) 171:1597–612.

  • Pubmed Abstract
  • Google Scholar

• 109.

  De LiberoGCasoratiGGiachinoCCarbonaraCMigoneNMatzingerPet al. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med. (1991) 173:1311–22.

  • Pubmed Abstract
  • Google Scholar

• 110.

  DimovaTBrouwerMGosselinFTassignonJLeoODonnerCet al. Effector Vgamma9Vdelta2 T cells dominate the human fetal gammadelta T-cell repertoire. Proc Natl Acad Sci USA. (2015) 112:E556–65. 10.1073/pnas.1412058112

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 111.

  MoritaCTJinCSarikondaGWangH. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev. (2007) 215:59–76. 10.1111/j.1600-065X.2006.00479.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 112.

  HarlyCGuillaumeYNedellecSPeigneCMMonkkonenHMonkkonenJet al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gammadelta T-cell subset. Blood (2012) 120:2269–79. 10.1182/blood-2012-05-430470

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 113.

  WangHHenryODistefanoMDWangYCRaikkonenJMonkkonenJet al. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vgamma2Vdelta2 T cells. J Immunol. (2013) 191:1029–42. 10.4049/jimmunol.1300658

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 114.

  VavassoriSKumarAWanGSRamanjaneyuluGSCavallariMElDaker Set al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells. Nat Immunol. (2013) 14:908–16. 10.1038/ni.2665

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 115.

  VantouroutPLaingAWoodwardMJZlatarevaIApoloniaLJonesAWet al. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing gammadelta T cell biology. Proc Natl Acad Sci USA. (2018) 115:1039–44. 10.1073/pnas.1701237115

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 116.

  De RosaSCAndrusJPPerfettoSPMantovaniJJHerzenbergLAHerzenbergLAet al. Ontogeny of gamma delta T cells in humans. J Immunol. (2004) 172:1637–45. 10.4049/jimmunol.172.3.1637

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 117.

  DieliFPocciaFLippMSireciGCaccamoNDi SanoCet al. Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. (2003) 198:391–7. 10.1084/jem.20030235

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 118.

  HoltmeierWPfanderMHennemannAZollnerTMKaufmannRCasparyWF. The TCR-delta repertoire in normal human skin is restricted and distinct from the TCR-delta repertoire in the peripheral blood. J Invest Dermatol. (2001) 116:275–80. 10.1046/j.1523-1747.2001.01250.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 119.

  DeuschKLulingFReichKClassenMWagnerHPfefferK. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol. (1991) 21:1053–9. 10.1002/eji.1830210429

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 120.

  HunterSWillcoxCRDaveyMSKasatskayaSAJefferyHCChudakovDMet al. Human liver infiltrating gammadelta T cells are composed of clonally expanded circulating and tissue-resident populations. J Hepatol. (2018) 69:654–65. 10.1016/j.jhep.2018.05.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 121.

  LuomaAMCastroCDMayassiTBembinsterLABaiLPicardDet al. Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity (2013) 39:1032–42. 10.1016/j.immuni.2013.11.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 122.

  UldrichAPLeNours JPellicciDGGherardinNAMcPhersonKGLimRTet al. CD1d-lipid antigen recognition by the gammadelta TCR. Nat Immunol. (2013) 14:1137–45. 10.1038/ni.2713

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 123.

  MarlinRPappalardoAKaminskiHWillcoxCRPitardVNetzerSet al. Sensing of cell stress by human gammadelta TCR-dependent recognition of annexin A2. Proc Natl Acad Sci USA. (2017) 114:3163–8. 10.1073/pnas.1621052114

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 124.

  DaveyMSWillcoxCRJoyceSPLadellKKasatskayaSAMcLarenJEet al. Clonal selection in the human Vdelta1 T cell repertoire indicates gammadelta TCR-dependent adaptive immune surveillance. Nat Commun. (2017) 8:14760. 10.1038/ncomms14760

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 125.

  PitardVRoumanesDLafargeXCouziLGarrigueILafonMEet al. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood (2008) 112:1317–24. 10.1182/blood-2008-01-136713

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 126.

  RavensSSchultze-FloreyCRahaSSandrockIDrenkerMOberdorferLet al. Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat Immunol. (2017) 18:393–401. 10.1038/ni.3686

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 127.

  CouziLPitardVNetzerSGarrigueILafonMEMoreauJFet al. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients. J Infect Dis. (2009) 200:1415–24. 10.1086/644509

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 128.

  HalaryFPitardVDlubekDKrzysiekRde la SalleHMervillePet al. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med. (2005) 201:1567–78. 10.1084/jem.20041851

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 129.

  KomanoHFujiuraYKawaguchiMMatsumotoSHashimotoYObanaSet al. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA. (1995) 92:6147–51.

  • Pubmed Abstract
  • Google Scholar

• 130.

  KohlgruberACGal-OzSTLaMarcheNMShimazakiMDuquetteDNguyenHNet al. gammadelta T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. Nat Immunol. (2018) 19:464–74. 10.1038/s41590-018-0094-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 131.

  VantouroutPHaydayA. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. (2013) 13:88–100. 10.1038/nri3384

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 132.

  LiuzziARKift-MorganALopez-AntonMFribergIMZhangJBrookACet al. Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. J Immunol. (2016) 197:2195–207. 10.4049/jimmunol.1600990

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 133.

  CaccamoNLaMendola COrlandoVMeravigliaSTodaroMStassiGet al. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood (2011) 118:129–38. 10.1182/blood-2011-01-331298

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 134.

  RomagnoliPASheridanBSPhamQMLefrancoisLKhannaKM. IL-17A-producing resident memory gammadelta T cells orchestrate the innate immune response to secondary oral Listeria monocytogenes infection. Proc Natl Acad Sci USA. (2016) 113:8502–7. 10.1073/pnas.1600713113

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 135.

  CaiYShenXDingCQiCLiKLiXet al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity (2011) 35:596–610. 10.1016/j.immuni.2011.08.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 136.

  GoberHJKistowskaMAngmanLJenoPMoriLDe LiberoG. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med. (2003) 197:163–8. 10.1084/jem.20021500

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 137.

  DieliFVermijlenDFulfaroFCaccamoNMeravigliaSCiceroGet al. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res. (2007) 67:7450–7. 10.1158/0008-5472.CAN-07-0199

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 138.

  ReiMGoncalves-SousaNLancaTThompsonRGMensuradoSBalkwillFRet al. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci USA. (2014) 111:E3562–70. 10.1073/pnas.1403424111

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 139.

  BhagatGNaiyerAJShahJGHarperJJabriBWangTCet al. Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest. (2008) 118:281–93. 10.1172/JCI30989

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 140.

  PengGWangHYPengWKiniwaYSeoKHWangRF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity (2007) 27:334–48. 10.1016/j.immuni.2007.05.020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 141.

  ChenYChouKFuchsEHavranWLBoismenuR. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA. (2002) 99:14338–43. 10.1073/pnas.212290499

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 142.

  HavranWLAllisonJP. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature (1988) 335:443–5. 10.1038/335443a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 143.

  XiongNRauletDH. Development and selection of gammadelta T cells. Immunol Rev. (2007) 215:15–31. 10.1111/j.1600-065X.2006.00478.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 144.

  LewisJMGirardiMRobertsSJBarbeeSDHaydayACTigelaarRE. Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant. Nat Immunol. (2006) 7:843–50. 10.1038/ni1363

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 145.

  BoydenLMLewisJMBarbeeSDBasAGirardiMHaydayACet al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nat Genet. (2008) 40:656–62. 10.1038/ng.108

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 146.

  BarbeeSDWoodwardMJTurchinovichGMentionJJLewisJMBoydenLMet al. Skint-1 is a highly specific, unique selecting component for epidermal T cells. Proc Natl Acad Sci USA. (2011) 108:3330–5. 10.1073/pnas.1010890108

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 147.

  JinYXiaMSaylorCMNarayanKKangJWiestDLet al. Cutting edge: Intrinsic programming of thymic gammadeltaT cells for specific peripheral tissue localization. J Immunol. (2010) 185:7156–60. 10.4049/jimmunol.1002781

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 148.

  KawaiKKishiharaKMolinaTJWallaceVAMakTWOhashiPS. Impaired development of V gamma 3 dendritic epidermal T cells in p56lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice. J Exp Med. (1995) 181:345–9.

  • Pubmed Abstract
  • Google Scholar

• 149.

  Mallick-WoodCAPaoWChengAMLewisJMKulkarniSBolenJBet al. Disruption of epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase. Proc Natl Acad Sci USA. (1996) 93:9704–9.

  • Pubmed Abstract
  • Google Scholar

• 150.

  KadlecekTAvan OersNSLefrancoisLOlsonSFinlayDChuDHet al. Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol. (1998) 161:4688–94.

  • Pubmed Abstract
  • Google Scholar

• 151.

  EndoYIshikawaONegishiI. Zeta-chain-associated protein-70 molecule is essential for the proliferation and the final maturation of dendritic epidermal T cells. Exp Dermatol. (2005) 14:188–93. 10.1111/j.0906-6705.2005.00264.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 152.

  XiongNKangCRauletDH. Positive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptors. Immunity (2004) 21:121–31. 10.1016/j.immuni.2004.06.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 153.

  XiaMQiQJinYWiestDLAugustAXiongN. Differential roles of IL-2-inducible T cell kinase-mediated TCR signals in tissue-specific localization and maintenance of skin intraepithelial T cells. J Immunol. (2010) 184:6807–14. 10.4049/jimmunol.1000453

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 154.

  JiangXCampbellJJKupperTS. Embryonic trafficking of gammadelta T cells to skin is dependent on E/P selectin ligands and CCR4. Proc Natl Acad Sci USA. (2010) 107:7443–8. 10.1073/pnas.0912943107

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 155.

  ChodaczekGPapannaVZalMAZalT. Body-barrier surveillance by epidermal gammadelta TCRs. Nat Immunol. (2012) 13:272–82. 10.1038/ni.2240

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 156.

  JamesonJMCauviGWitherdenDAHavranWL. A keratinocyte-responsive gamma delta TCR is necessary for dendritic epidermal T cell activation by damaged keratinocytes and maintenance in the epidermis. J Immunol. (2004) 172:3573–9. 10.4049/jimmunol.172.6.3573

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 157.

  KomoriHKWitherdenDAKellyRSendaydiegoKJamesonJMTeytonLet al. Cutting edge: dendritic epidermal gammadelta T cell ligands are rapidly and locally expressed by keratinocytes following cutaneous wounding. J Immunol. (2012) 188:2972–6. 10.4049/jimmunol.1100887

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 158.

  StridJSobolevOZafirovaBPolicBHaydayA. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science (2011) 334:1293–7. 10.1126/science.1211250

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 159.

  HavranWLChienYHAllisonJP. Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science (1991) 252:1430–2.

  • Pubmed Abstract
  • Google Scholar

• 160.

  WitherdenDAWatanabeMGarijoORiederSESarkisyanGCroninSJet al. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal gammadelta T cell function. Immunity (2012) 37:314–25. 10.1016/j.immuni.2012.05.026

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 161.

  WhangMIGuerraNRauletDH. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin. J Immunol. (2009) 182:4557–64. 10.4049/jimmunol.0802439

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 162.

  YoshidaSMohamedRHKajikawaMKoizumiJTanakaMFugoKet al. Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound repair. J Immunol. (2012) 188:3972–9. 10.4049/jimmunol.1102886

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 163.

  MacLeodASHemmersSGarijoOChabodMMowenKWitherdenDAet al. Dendritic epidermal T cells regulate skin antimicrobial barrier function. J Clin Invest. (2013) 123:4364–74. 10.1172/JCI70064

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 164.

  BoismenuRFengLXiaYYChangJCHavranWL. Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol. (1996) 157:985–92.

  • Pubmed Abstract
  • Google Scholar

• 165.

  MacLeodASRudolphRCorridenRYeIGarijoOHavranWL. Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair. J Immunol. (2014) 192:5695–702. 10.4049/jimmunol.1303297

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 166.

  CrawfordGHayesMDSeoaneRCWardSDalessandriTLaiCet al. Epithelial damage and tissue gammadelta T cells promote a unique tumor-protective IgE response. Nat Immunol. (2018) 19:859–70. 10.1038/s41590-018-0161-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 167.

  GebhardtTWhitneyPGZaidAMackayLKBrooksAGHeathWRet al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature (2011) 477:216–9. 10.1038/nature10339

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 168.

  ZaidAMackayLKRahimpourABraunAVeldhoenMCarboneFRet al. Persistence of skin-resident memory T cells within an epidermal niche. Proc Natl Acad Sci USA. (2014) 111:5307–12. 10.1073/pnas.1322292111

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 169.

  PutturFKFernandezMAWhiteRRoedigerBCunninghamALWeningerWet al. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol. (2010) 185:477–87. 10.4049/jimmunol.0904106

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 170.

  MuellerSNZaidACarboneFR. Tissue-resident T cells: dynamic players in skin immunity. Front Immunol. (2014) 5:332. 10.3389/fimmu.2014.00332

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 171.

  KawaiKSuzukiHTomiyamaKMinagawaMMakTWOhashiPS. Requirement of the IL-2 receptor beta chain for the development of Vgamma3 dendritic epidermal T cells. J Invest Dermatol. (1998) 110:961–5. 10.1046/j.1523-1747.1998.00214.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 172.

  De CreusAVan BenedenKStevenaertFDebackerVPlumJLeclercqG. Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-1-deficient mice. J Immunol. (2002) 168:6486–93. 10.4049/jimmunol.168.12.6486

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 173.

  KadowSJuxBZahnerSPWingerathBChmillSClausenBEet al. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis. J Immunol. (2011) 187:3104–10. 10.4049/jimmunol.1100912

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 174.

  LiYInnocentinSWithersDRRobertsNAGallagherARGrigorievaEFet al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell. (2011) 147:629–40. 10.1016/j.cell.2011.09.025

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 175.

  ParkSLZaidAHorJLChristoSNPrierJEDaviesBet al. Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses. Nat Immunol. (2018) 19:183–91. 10.1038/s41590-017-0027-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 176.

  GoodmanTLefrancoisL. Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature (1988) 333:855–8. 10.1038/333855a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 177.

  LefrancoisLPuddingtonL. The role of the thymus in intestinal intraepithelial T-cell development. Ann N Y Acad Sci. (1996) 778:36–46.

  • Pubmed Abstract
  • Google Scholar

• 178.

  BandeiraAMota-SantosTItoharaSDegermannSHeusserCTonegawaSet al. Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med. (1990) 172:239–44.

  • Pubmed Abstract
  • Google Scholar

• 179.

  BandeiraAItoharaSBonnevilleMBurlen-DefranouxOMota-SantosTCoutinhoAet al. Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc Natl Acad Sci USA, (1991) 88:43–7.

  • Pubmed Abstract
  • Google Scholar

• 180.

  Di Marco BarrosRRobertsNADartRJVantouroutPJandkeANussbaumerOet al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific gammadelta T Cell Compartments. Cell (2016) 167:203–18 e17. 10.1016/j.cell.2016.08.030

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 181.

  LakyKLefrancoisLvonFreeden-Jeffry UMurrayRPuddingtonL. The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells. J Immunol. (1998) 161:707–13.

  • Pubmed Abstract
  • Google Scholar

• 182.

  LakyKLefrancoisLLingenheldEGIshikawaHLewisJMOlsonSet al. Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J Exp Med. (2000) 191:1569–80. 10.1084/jem.191.9.1569

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 183.

  TakagakiYDeClouxABonnevilleMTonegawaS. Diversity of gamma delta T-cell receptors on murine intestinal intra-epithelial lymphocytes. Nature (1989) 339:712–4. 10.1038/339712a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 184.

  ZhaoHNguyenHKangJ. Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes. Nat Immunol. (2005) 6:1263–71. 10.1038/ni1267

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 185.

  ShinSEl-DiwanyRSchaffertSAdamsEJGarciaKCPereiraPet al. Antigen recognition determinants of gammadelta T cell receptors. Science (2005) 308:252–5. 10.1126/science.1106480

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 186.

  KunisawaJKurashimaYHiguchiMGohdaMIshikawaIOgaharaIet al. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J Exp Med. (2007) 204:2335–48. 10.1084/jem.20062446

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 187.

  WurbelMAMalissenMGuy-GrandDMeffreENussenzweigMCRichelmeMet al. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood (2001) 98:2626–32. 10.1182/blood.V98.9.2626

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 188.

  ChennupatiVWorbsTLiuXMalinarichFHSchmitzSHaasJDet al. Intra- and intercompartmental movement of gammadelta T cells: intestinal intraepithelial and peripheral gammadelta T cells represent exclusive nonoverlapping populations with distinct migration characteristics. J Immunol. (2010) 185:5160–8. 10.4049/jimmunol.1001652

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 189.

  Guy-GrandDVassalliPEberlGPereiraPBurlen-DefranouxOLemaitreFet al. Origin, trafficking, and intraepithelial fate of gut-tropic T cells. J Exp Med. (2013) 210:1839–54. 10.1084/jem.20122588

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 190.

  JensenKDShinSChienYH. Cutting edge: Gammadelta intraepithelial lymphocytes of the small intestine are not biased toward thymic antigens. J Immunol. (2009) 182:7348–51. 10.4049/jimmunol.0900465

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 191.

  LodolceJPBooneDLChaiSSwainREDassopoulosTTrettinSet al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity (1998) 9:669–76.

  • Pubmed Abstract
  • Google Scholar

• 192.

  KennedyMKGlaccumMBrownSNButzEAVineyJLEmbersMet al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. (2000) 191:771–80. 10.1084/jem.191.5.771

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 193.

  YuQTangCXunSYajimaTTakedaKYoshikaiY. MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8 alpha alpha TCR alpha beta and TCR gamma delta intestinal intraepithelial lymphocytes. J Immunol. (2006) 176:6180–5. 10.4049/jimmunol.176.10.6180

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 194.

  FahrerAMKonigshoferYKerrEMGhandourGMackDHDavisMMet al. Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc Natl Acad Sci USA. (2001) 98:10261–6. 10.1073/pnas.171320798

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 195.

  LefrancoisLGoodmanT. In vivo modulation of cytolytic activity and Thy-1 expression in TCR-gamma delta+ intraepithelial lymphocytes. Science (1989) 243:1716–8.

  • Pubmed Abstract
  • Google Scholar

• 196.

  SwamyMAbeler-DornerLChettleJMahlakoivTGoubauDChakravartyPet al. Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance. Nat Commun. (2015) 6:7090. 10.1038/ncomms8090

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 197.

  IsmailASBehrendtCLHooperLV. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol. (2009) 182:3047–54. 10.4049/jimmunol.0802705

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 198.

  EdelblumKLShenLWeberCRMarchiandoAMClayBSWangYet al. Dynamic migration of gammadelta intraepithelial lymphocytes requires occludin. Proc Natl Acad Sci USA. (2012) 109:7097–102. 10.1073/pnas.1112519109

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 199.

  MalinarichFHGrabskiEWorbsTChennupatiVHaasJDSchmitzSet al. Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial gammadelta T cells is functional in vivo. Eur J Immunol. (2010) 40:3378–88. 10.1002/eji.201040727

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 200.

  RidauraVKBouladouxNClaesenJChenYEByrdALConstantinidesMGet al. Contextual control of skin immunity and inflammation by Corynebacterium. J Exp Med. (2018) 215:785–99. 10.1084/jem.20171079

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 201.

  FlemingCCaiYSunXJalaVRXueFMorrisseySet al. Microbiota-activated CD103(+) DCs stemming from microbiota adaptation specifically drive gammadeltaT17 proliferation and activation. Microbiome (2017) 5:46. 10.1186/s40168-017-0263-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 202.

  VeldhoenM. Interleukin 17 is a chief orchestrator of immunity. Nat Immunol. (2017) 18:612–21. 10.1038/ni.3742

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 203.

  ArunachalamPLudewigPMelichPArumugamTVGerloffCPrinzIet al. CCR6 (CC Chemokine Receptor 6) Is Essential for the Migration of Detrimental Natural Interleukin-17-Producing gammadelta T Cells in Stroke. Stroke (2017) 48:1957–65. 10.1161/STROKEAHA.117.016753

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 204.

  ShichitaTSugiyamaYOoboshiHSugimoriHNakagawaRTakadaIet al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. (2009) 15:946–50. 10.1038/nm.1999

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 205.

  GelderblomMWeymarABernreutherCVeldenJArunachalamPSteinbachKet al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. (2012) 120:3793–802. 10.1182/blood-2012-02-412726

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 206.

  BelkaidYHandTW. Role of the microbiota in immunity and inflammation. Cell. (2014) 157:121–41. 10.1016/j.cell.2014.03.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 207.

  MairFJollerSHoeppliROnderLHahnMLudewigBet al. The NFkappaB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing gammadelta T cells. Elife (2015) 4:e10087. 10.7554/eLife.10087

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 208.

  McKenzieDRKaraEEBastowCRTyllisTSFenixKAGregorCEet al. IL-17-producing gammadelta T cells switch migratory patterns between resting and activated states. Nat Commun. (2017) 8:15632. 10.1038/ncomms15632

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 209.

  DechanetJMervillePBergeFBone-ManeGTaupinJLMichelPet al. Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis. (1999) 179:1–8. 10.1086/314568

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 210.

  LafargeXMervillePCazinMCBergeFPotauxLMoreauJFet al. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis. (2001) 184:533–41. 10.1086/322843

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 211.

  Puig-PeyIBohneFBenitezCLopezMMartinez-LlordellaMOppenheimerFet al. Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int. (2010) 23:1045–55. 10.1111/j.1432-2277.2010.01095.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 212.

  PrinzIThammKPortMWeissingerEMStadlerMGabaevIet al. Donor Vdelta1+ gammadelta T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL. Exp Hematol Oncol. (2013) 2:14. 10.1186/2162-3619-2-14

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 213.

  FornaraCLilleriDRevelloMGFurioneMZavattoniMLentaEet al. Kinetics of effector functions and phenotype of virus-specific and gammadelta T lymphocytes in primary human cytomegalovirus infection during pregnancy. J Clin Immunol. (2011) 31:1054–64. 10.1007/s10875-011-9577-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 214.

  EhlSSchwarzKEndersADuffnerUPannickeUKuhrJet al. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest. (2005) 115:3140–8. 10.1172/JCI25221

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 215.

  de VillartayJPLimAAl-MousaHDupontSDechanet-MervilleJCoumau-GatboisEet al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. (2005) 115:3291–9. 10.1172/JCI25178

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 216.

  VermijlenDBrouwerMDonnerCLiesnardCTackoenMVan RysselbergeMet al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med. (2010) 207:807–21. 10.1084/jem.20090348

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 217.

  KhairallahCNetzerSVillacrecesAJuzanMRousseauBDulantoSet al. gammadelta T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathog. (2015) 11:e1004702. 10.1371/journal.ppat.1004702

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 218.

  SellSDietzMSchneiderAHoltappelsRMachMWinklerTH. Control of murine cytomegalovirus infection by gammadelta T cells. PLoS Pathog. (2015) 11:e1004481. 10.1371/journal.ppat.1004481

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 219.

  WilkMMMisiakAMcManusRMAllenACLynchMAMillsKHG. Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. J Immunol. (2017) 199:233–43. 10.4049/jimmunol.1602051

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 220.

  ConstantPDavodeauFPeyratMAPoquetYPuzoGBonnevilleMet al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science. (1994) 264:267–70.

  • Pubmed Abstract
  • Google Scholar

• 221.

  FournieJJBonnevilleM. Stimulation of gamma delta T cells by phosphoantigens. Res Immunol. (1996) 147:338–47.

  • Pubmed Abstract
  • Google Scholar

• 222.

  MoritaCTMariuzzaRABrennerMB. Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol. (2000) 22:191–217. 10.1007/s002810000042

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 223.

  HoftDFBrownRMRoodmanST. Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J Immunol. (1998) 161:1045–54.

  • Pubmed Abstract
  • Google Scholar

• 224.

  BertottoASpinozziFGerliRBassottiGForenzaNVagliasindiCet al. Peripheral blood gamma delta T cells in human listeriosis. Acta Paediatr. (1995) 84:1434–5.

  • Pubmed Abstract
  • Google Scholar

• 225.

  Jouen-BeadesFParisEDieuloisCLemelandJFBarre-DezelusVMarretSet al. In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans. Infect Immun. (1997) 65:4267–72.

  • Pubmed Abstract
  • Google Scholar

• 226.

  MunkMEElserCKaufmannSH. Human gamma/delta T-cell response to Listeria monocytogenes protein components in vitro. Immunology (1996) 87:230–5.

  • Pubmed Abstract
  • Google Scholar

• 227.

  BegleyMGahanCGKollasAKHintzMHillCJomaaHet al. The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. FEBS Lett. (2004) 561:99–104. 10.1016/S0014-5793(04)00131-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 228.

  OhgaSYoshikaiYTakedaYHiromatsuKNomotoK. Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur J Immunol. (1990) 20:533–8. 10.1002/eji.1830200311

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 229.

  SkeenMJZieglerHK. Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection. J Exp Med. (1993) 178:971–84.

  • Pubmed Abstract
  • Google Scholar

• 230.

  MatsuzakiGHiromatsuKYoshikaiYMuramoriKNomotoK. Characterization of T-cell receptor gamma delta T cells appearing at the early phase of murine Listeria monocytogenes infection. Immunology. (1993) 78:22–7.

  • Pubmed Abstract
  • Google Scholar

• 231.

  NakamuraTMatsuzakiGNomotoK. The protective role of T-cell receptor Vgamma1+ T cells in primary infection with Listeria monocytogenes. Immunology (1999) 96:29–34.

  • Pubmed Abstract
  • Google Scholar

• 232.

  RoarkCEVollmerMKCampbellPABornWKO'BrienRL. Response of a gamma delta+ T cell receptor invariant subset during bacterial infection. J Immunol. (1996) 156:2214–20.

  • Pubmed Abstract
  • Google Scholar

• 233.

  RoarkCLAydintugMKLewisJYinXLahnMHahnYSet al. Subset-specific, uniform activation among V gamma 6/V delta 1+ gamma delta T cells elicited by inflammation. J Leukoc Biol. (2004) 75:68–75. 10.1189/jlb.0703326

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 234.

  HamadaSUmemuraMShionoTHaraHKishiharaKTanakaKet al. Importance of murine Vdelta1gammadelta T cells expressing interferon-gamma and interleukin-17A in innate protection against Listeria monocytogenes infection. Immunology (2008) 125:170–7. 10.1111/j.1365-2567.2008.02841.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 235.

  SunXShibataKYamadaHGuoYMutaHPodackERet al. CD30L/CD30 is critical for maintenance of IL-17A-producing gammadelta T cells bearing Vgamma6 in mucosa-associated tissues in mice. Mucosal Immunol. (2013) 6:1191–201. 10.1038/mi.2013.18

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 236.

  MeeksKDSieveANKollsJKGhilardiNBergRE. IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol. (2009) 183:8026–34. 10.4049/jimmunol.0901588

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 237.

  HamadaSUmemuraMShionoTTanakaKYahagiABegumMDet al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol. (2008) 181:3456–63. 10.4049/jimmunol.181.5.3456

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 238.

  TramontiDAndrewEMRhodesKNewtonDJCardingSR. Evidence for the opposing roles of different gamma delta T cell subsets in macrophage homeostasis. Eur J Immunol. (2006) 36:1729–38. 10.1002/eji.200635959

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 239.

  DaltonJEPearsonJScottPCardingSR. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. J Immunol. (2003) 171:6488–94. 10.4049/jimmunol.171.12.6488

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 240.

  DaltonJEHowellGPearsonJScottPCardingSR. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol. (2004) 173:3660–7. 10.4049/jimmunol.173.6.3660

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 241.

  AndrewEMNewtonDJDaltonJEEganCEGoodwinSJTramontiDet al. Delineation of the function of a major gamma delta T cell subset during infection. J Immunol. (2005) 175:1741–50. 10.4049/jimmunol.175.3.1741

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 242.

  SkeenMJZieglerHK. Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol. (1995) 154:5832–41.

  • Pubmed Abstract
  • Google Scholar

• 243.

  SkeenMJRixEPFreemanMMZieglerHK. Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes. Infect Immun. (2001) 69:7213–23. 10.1128/IAI.69.12.7213-7223.2001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 244.

  NewtonDJAndrewEMDaltonJEMearsRCardingSR. Identification of novel gammadelta T-cell subsets following bacterial infection in the absence of Vgamma1+ T cells: homeostatic control of gammadelta T-cell responses to pathogen infection by Vgamma1+ T cells. Infect Immun. (2006) 74:1097–105. 10.1128/IAI.74.2.1097-1105.2006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 245.

  HasegawaTTanakaTYoshikaiY. The appearance and role of gamma delta T cells in the peritoneal cavity and liver during primary infection with Listeria monocytogenes in rats. Int Immunol. (1992) 4:1129–36.

  • Pubmed Abstract
  • Google Scholar

• 246.

  KimuraYTomidaSMatsumotoYHiromatsuKYoshikaiY. Evidence for the early recruitment of T-cell receptor gamma delta+ T cells during rat listeriosis. Immunology. (1996) 87:21–8.

  • Pubmed Abstract
  • Google Scholar

• 247.

  WollertTPascheBRochonMDeppenmeierSvan den HeuvelJGruberADet al. Extending the host range of Listeria monocytogenes by rational protein design. Cell (2007) 129:891–902. 10.1016/j.cell.2007.03.049

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 248.

  SheridanBSPhamQMLeeYTCauleyLSPuddingtonLLefrancoisL. Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. Immunity (2014) 40:747–57. 10.1016/j.immuni.2014.03.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 249.

  RomagnoliPAFuHHQiuZKhairallahCPhamQMPuddingtonLet al. Differentiation of distinct long-lived memory CD4 T cells in intestinal tissues after oral Listeria monocytogenes infection. Mucosal Immunol. (2017) 10:520–30. 10.1038/mi.2016.66

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 250.

  GentlesAJNewmanAMLiuCLBratmanSVFengWKimDet al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. (2015) 21:938–45. 10.1038/nm.3909

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 251.

  ZocchiMRCostaDVeneRTosettiFFerrariNMinghelliSet al. Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector gammadelta T cells with antitumor activity. Oncoimmunology (2017) 6:e1278099. 10.1080/2162402X.2016.1278099

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 252.

  ZhouDYQinJHuangJWangFXuGPLvYTet al. Zoledronic acid inhibits infiltration of tumor-associated macrophages and angiogenesis following transcatheter arterial chemoembolization in rat hepatocellular carcinoma models. Oncol Lett. (2017) 14:4078–84. 10.3892/ol.2017.6717

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 253.

  BrazaMSKleinB. Anti-tumour immunotherapy with Vgamma9Vdelta2 T lymphocytes: from the bench to the bedside. Br J Haematol. (2013) 160:123–32. 10.1111/bjh.12090

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 254.

  WrobelPShojaeiHSchittekBGieselerFWollenbergBKalthoffHet al. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol. (2007) 66:320–8. 10.1111/j.1365-3083.2007.01963.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 255.

  TodaroMD'AsaroMCaccamoNIovinoFFrancipaneMGMeravigliaSet al. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol. (2009) 182:7287–96. 10.4049/jimmunol.0804288

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 256.

  GomesAQCorreiaDVGrossoARLancaTFerreiraCLacerdaJFet al. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells. Haematologica (2010) 95:1397–404. 10.3324/haematol.2009.020602

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 257.

  Gertner-DardenneJCastellanoRMamessierEGarbitSKochbatiEEtienneAet al. Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol. (2012) 188:4701–8. 10.4049/jimmunol.1103710

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 258.

  BerglundSGaballaASawaisornPSundbergBUhlinM. Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility. Stem Cells Int. (2018) 2018:8529104. 10.1155/2018/8529104

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 259.

  CapsomidisABenthallGVan AckerHHFisherJKramerAMAbelnZet al. Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation. Mol Ther. (2018) 26:354–65. 10.1016/j.ymthe.2017.12.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 260.

  MeravigliaSEberlMVermijlenDTodaroMBuccheriSCiceroGet al. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol. (2010) 161:290–7. 10.1111/j.1365-2249.2010.04167.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 261.

  CapiettoAHMartinetLFournieJJ. Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer. J Immunol. (2011) 187:1031–8. 10.4049/jimmunol.1100681

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 262.

  KabelitzDWeschDPittersEZollerM. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo. J Immunol. (2004) 173:6767–76. 10.4049/jimmunol.173.11.6767

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 263.

  D'AsaroMLaMendola CDi LibertoDOrlandoVTodaroMSpinaMet al. V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. J Immunol. (2010) 184:3260–8. 10.4049/jimmunol.0903454

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 264.

  SugaiSYoshikawaTIwamaTTsuchiyaNUedaNFujinamiNet al. Hepatocellular carcinoma cell sensitivity to Vgamma9Vdelta2 T lymphocyte-mediated killing is increased by zoledronate. Int J Oncol. (2016) 48:1794–804. 10.3892/ijo.2016.3403

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 265.

  ZumwaldeNAHaagJDSharmaDMirrieleesJAWilkeLGGouldMNet al. Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vdelta2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate. Cancer Prev Res. (2016) 9:305–16. 10.1158/1940-6207.CAPR-15-0370-T

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 266.

  YoshikawaTTakaharaMTomiyamaMNiedaMMaekawaRNakatsuraT. Large-scale expansion of gammadelta T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy. Int J Oncol. (2014) 45:1847–56. 10.3892/ijo.2014.2634

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 267.

  NakazawaTNakamuraMParkYSMotoyamaYHironakaYNishimuraFet al. Cytotoxic human peripheral blood-derived gammadeltaT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma. J Neurooncol. (2014) 116:31–9. 10.1007/s11060-013-1258-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 268.

  KaiserADAssenmacherMSchroderBMeyerMOrentasRBethkeUet al. Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Ther. (2015) 22:72–8. 10.1038/cgt.2014.78

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 269.

  MussoACatellaniSCanevaliPTavellaSVeneRBoeroSet al. Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vdelta 2 T lymphocytes in non-Hodgkin lymphomas. Haematologica (2014) 99:131–9. 10.3324/haematol.2013.097311

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 270.

  FowlerDWCopierJDalgleishAGBodman-SmithMD. Zoledronic acid causes gammadelta T cells to target monocytes and down-modulate inflammatory homing. Immunology. (2014) 143:539–49. 10.1111/imm.12331

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 271.

  WeltonJLMorganMPMartiSStoneMDMoserBSewellAKet al. Monocytes and gammadelta T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res. (2013) 28:464–71. 10.1002/jbmr.1797

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 272.

  KalyanSChandrasekaranVQuabiusESLindhorstTKKabelitzD. Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood gammadelta T cells. Cell Mol Life Sci. (2014) 71:2335–46. 10.1007/s00018-013-1495-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 273.

  BansalPSonnenbergA. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology (1995) 109:247–51.

  • Pubmed Abstract
  • Google Scholar

• 274.

  ChiesaFuxench ZCShinDBOgdieBeatty AGelfandJM. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network. JAMA Dermatol. (2016) 152:282–90. 10.1001/jamadermatol.2015.4847

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 275.

  JessTRungoeCPeyrin-BirouletL. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. (2012) 10:639–45. 10.1016/j.cgh.2012.01.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 276.

  BrockmannLGiannouADGaglianiNHuberS. Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis. Int J Mol Sci. (2017) 18:1033. 10.3390/ijms18051033

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 277.

  TseSWRadtkeAJEspinosaDACockburnIAZavalaF. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8(+) T cells specific for infectious pathogens. J Infect Dis. (2014) 210:1508–16. 10.1093/infdis/jiu281

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 278.

  DevaudCBilhereELoizonSPitardVBehrCMoreauJFet al. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model. Cancer Res. (2009) 69:3971–8. 10.1158/0008-5472.CAN-08-3037

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 279.

  DevaudCRousseauBNetzerSPitardVParoissinCKhairallahCet al. Anti-metastatic potential of human Vdelta1(+) gammadelta T cells in an orthotopic mouse xenograft model of colon carcinoma. Cancer Immunol Immunother. (2013) 62:1199–210. 10.1007/s00262-013-1402-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 280.

  HenaultJRiggsJMKarnellJLLiarskiVMLiJShirinianLet al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. (2016) 17:196–203. 10.1038/ni.3326

  • Pubmed Abstract
  • CrossRef
  • Google Scholar